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Foreword 
 
The evaluation of research and doctoral training is being carried out in the years 2010–2012 and will end in 
2012. The steering group appointed by the Rector in January 2010 set the conditions for participating in 
the evaluation and prepared the Terms of Reference to present the evaluation procedure and criteria. The 
publications and other scientific activities included in the evaluation covered the years 2005–2010. 
The participating unit in the evaluation was defined as a Researcher Community (RC). To obtain a 
critical mass with university-level impact, the number of members was set to range from 20 to 120. The 
RCs were required to contain researchers in all stages of their research career, from doctoral students to 
principal investigators (PIs). All in all, 136 Researcher Communities participated in this voluntary 
evaluation, 5857 persons in total, of whom 1131 were principal investigators. PIs were allowed to 
participate in two communities in certain cases, and 72 of them used this opportunity and participated in 
two RCs. 
This evaluation enabled researchers to define RCs from the “bottom up” and across disciplines. The aim 
of the evaluation was not to assess individual performance but a community with shared aims and 
researcher-training activities. The RCs were able to choose among five different categories that 
characterised the status and main aims of their research. The steering group considered the process of 
applying to participate in the evaluation to be important, which lead to the establishment of these 
categories. In addition, providing a service for the RCs to enable them to benchmark their research at the 
global level was a main goal of the evaluation. 
The data for the evaluation consisted of the RCs’ answers to evaluation questions on supplied e-forms 
and a compilation extracted from the TUHAT – Research Information System (RIS) on 12 April 2011. The 
compilation covered scientific and other publications as well as certain areas of scientific activities. During 
the process, the RCs were asked to check the list of publications and other scientific activities and make 
corrections if needed. These TUHAT compilations are public and available on the evaluation project sites 
of each RC in the TUHAT-RIS. 
In addition to the e-form and TUHAT compilation, University of Leiden (CWTS) carried out bibliometric 
analyses from the articles included in the Web of Science (WoS). This was done on University and RC 
levels. In cases where the publication forums of the RC were clearly not represented by the WoS data, the 
Library of the University of Helsinki conducted a separate analysis of the publications. This was done for 
66 RCs representing the humanities and social sciences. 
The evaluation office also carried out an enquiry targeted to the supervisors and PhD candidates about 
the organisation of doctoral studies at the University of Helsinki. This and other documents describing the 
University and the Finnish higher education system were provided to the panellists. 
The panel feedback for each RC is unique and presented as an entity. The first collective evaluation 
reports available for the whole panel were prepared in July–August 2011. The reports were accessible to all 
panel members via the electronic evaluation platform in August. Scoring from 1 to 5 was used to 
complement written feedback in association with evaluation questions 1–4 (scientific focus and quality, 
doctoral training, societal impact, cooperation) and in addition to the category evaluating the fitness for 
participation in the evaluation. Panellists used the international level as a point of comparison in the 
evaluation. Scoring was not expected to go along with a preset deviation. 
Each of the draft reports were discussed and dealt with by the panel in meetings in Helsinki (from 11 
September to 13 September or from 18 September to 20 September 2011). In these meetings the panels 
also examined the deviations among the scores and finalised the draft reports together. 
The current RC-specific report deals shortly with the background of the evaluation and the terms of 
participation. The main evaluation feedback is provided in the evaluation report, organised according to 
the evaluation questions. The original material provided by the RCs for the panellists has been attached to 
these documents. 
 
 
 
 
 
 
 
 
 
On behalf of the evaluation steering group and office, I sincerely wish to thank you warmly for your 
participation in this evaluation. The effort you made in submitting the data to TUHAT-RIS is gratefully 
acknowledged by the University. We wish that you find this panel feedback useful in many ways. The 
bibliometric profiles may open a new view on your publication forums and provide a perspective for 
discussion on your choice of forums. We especially hope that this evaluation report will help you in setting 
the future goals of your research. 
 
Johanna Björkroth 
Vice-Rector 
Chair of the Steering Group of the Evaluation 
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Panel members 
CHAIR 
Professor Lorenz Poellinger 
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Karolinska Institute, Sweden 
 
VICE-CHAIR 
Professor Cornelia van Duijn 
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Erasmus Medical Centre, the Netherlands 
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Molecular cell biology, cell adhesion, cancer biology 
University of Turku, VTT Technical Research Centre, Finland 
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University of Turku, Finland 
 
Professor Hans-Christian Pape 
Neuroscience, neurophysiology 
University of Münster, Germany 
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Karolinska Institute, Sweden 
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The panel, independently, evaluated all the submitted material and was responsible for the 
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discussion and report writing. 
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Dr Seppo Saari, Doc., Senior Adviser in Evaluation, was responsible for the entire 
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reports. 
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TUHAT OFFICE 
Provision of the publication and other scientific activity data 
Mrs Aija Kaitera, Project Manager of TUHAT-RIS served the project ex officio 
providing the evaluation project with the updated information from TUHAT-RIS. 
The TUHAT office assisted in mapping the publications with CWTS/University of 
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MA Liisa Ekebom, Assisting Officer, served in TUHAT-RIS updating the 
publications for the evaluation. She also assisted the UH/Library analyses. 
BA Liisa Jäppinen, Assisting Officer, served in TUHAT-RIS updating the 
publications for the evaluation. 
 
HELSINKI UNIVERSITY LIBRARY 
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sciences and in other fields of sciences where CWTS analyses were not 
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Acronyms and abbreviations applied in the report 
 
External competitive funding 
AF – Academy of Finland 
TEKES - Finnish Funding Agency for Technology and Innovation  
EU - European Union 
ERC - European Research Council 
International and national foundations 
FP7/6 etc. /Framework Programmes/Funding of European Commission 
 
Evaluation marks 
Outstanding (5) 
Excellent  (4) 
Very Good  (3) 
Good  (2) 
Sufficient  (1) 
 
Abbreviations of Bibliometric Indicators 
P - Number of publications 
TCS – Total number of citations 
MCS - Number of citations per publication, excluding self-citations 
PNC - Percentage of uncited publications 
MNCS - Field-normalized number of citations per publication 
MNJS - Field-normalized average journal impact 
THCP10 - Field-normalized proportion highly cited publications (top 10%) 
INT_COV - Internal coverage, the average amount of references covered by the WoS 
WoS – Thomson Reuters Web of Science Databases 
 
Participation category 
Category 1. The research of the participating community represents the international cutting edge in its 
field. 
Category 2. The research of the participating community is of high quality, but the community in its 
present composition has yet to achieve strong international recognition or a clear break-through. 
Category 3. The research of the participating community is distinct from mainstream research, and the 
special features of the research tradition in the field must be considered in the evaluation. 
Category 4. The research of the participating community represents an innovative opening. 
Category 5. The research of the participating community has a highly significant societal impact. 
 
Research focus areas of the University of Helsinki 
Focus area 1: The basic structure, materials and natural resources of the physical world 
Focus area 2: The basic structure of life 
Focus area 3: The changing environment – clean water 
Focus area 4: The thinking and learning human being 
Focus area 5: Welfare and safety 
Focus area 6: Clinical research 
Focus area 7: Precise reasoning 
Focus area 8: Language and culture 
Focus area 9: Social justice 
Focus area 10: Globalisation and social change 
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1 Introduction to the Evaluation 
1.1 RC-specific evaluation reports 
The participants in the evaluation of research and doctoral training were Researcher Communities 
(hereafter referred to as the RC). The RC refers to the group of researchers who registered together in the 
evaluation of their research and doctoral training. Preconditions in forming RCs were stated in the 
Guidelines for the Participating Researcher Communities. The RCs defined themselves whether their 
compositions should be considered well-established or new. 
It is essential to emphasise that the evaluation combines both meta-evaluation1 and traditional 
research assessment exercise and its focus is both on the research outcomes and procedures associated 
with research and doctoral training. The approach to the evaluation is enhancement-led where self-
evaluation constituted the main information. The answers to the evaluation questions formed together 
with the information of publications and other scientific activities an entity that was to be reviewed as a 
whole. 
The present evaluation recognizes and justifies the diversity of research practices and publication 
traditions. Traditional Research Assessment Exercises do not necessarily value high quality research with 
low volumes or research distinct from mainstream research. It is challenging to expose the diversity of 
research to fair comparison. To understand the essence of different research practices and to do justice to 
their diversity was one of the main challenges of the present evaluation method. Understanding the 
divergent starting points of the RCs demanded sensitivity from the evaluators. 
1.2 Aims and objectives in the evaluation 
The aims of the evaluation are as follows: 
 to improve the level of research and doctoral training at the University of Helsinki and to raise 
their international profile in accordance with the University’s strategic policies. The improvement 
of doctoral training should be compared to the University’s policy.2 
 to enhance the research conducted at the University by taking into account the diversity, 
originality, multidisciplinary nature, success and field-specificity, 
 to recognize the conditions and prerequisites under which excellent, original and high-impact 
research is carried out, 
 to offer the academic community the opportunity to receive topical and versatile international 
peer feedback, 
 to better recognize the University’s research potential. 
 to exploit the University’s TUHAT research information system to enable transparency of 
publishing activities and in the production of reliable, comparable data. 
1.3 Evaluation method 
The evaluation can be considered as an enhancement-led evaluation. Instead of ranking, the main aim is to 
provide useful information for the enhancement of research and doctoral training of the participating RCs. 
The comparison should take into account each field of science and acknowledge their special character. 
                                                                
1 The panellists did not read research reports or abstracts but instead, they evaluated answers to the evaluation 
questions, tables and compilations of publications, other scientific activities, bibliometrics or comparable analyses. 
2
 Policies on doctoral degrees and other postgraduate degrees at the University of Helsinki.  
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The comparison produced information about the present status and factors that have lead to success. Also 
challenges in the operations and outcomes were recognized. 
The evaluation approach has been designed to recognize better the significance and specific nature of 
researcher communities and research areas in the multidisciplinary top-level university. Furthermore, one 
of the aims of the evaluation is to bring to light those evaluation aspects that differ from the prevalent 
ones. Thus the views of various fields of research can be described and research arising from various 
starting points understood better. The doctoral training is integrated into the evaluation as a natural 
component related to research. Operational processes of doctoral training are being examined in the 
evaluation. 
 
Five stages of the evaluation method were: 
1. Registration – Stage 1 
2. Self-evaluation – Stage 2 
3. TUHAT3 compilations on publications and other scientific activities4 
4. External evaluation 
5. Public reporting 
1.4 Implementation of the external evaluation 
Five Evaluation Panels 
Five evaluation panels consisted of independent, renowned and highly respected experts. The main 
domains of the panels are: 
1. biological, agricultural and veterinary sciences 
2. medicine, biomedicine and health sciences 
3. natural sciences 
4. humanities 
5. social sciences 
The University invited 10 renowned scientists to act as chairs or vice-chairs of the five panels based on 
the suggestions of faculties and independent institutes. Besides leading the work of the panel, an 
additional role of the chairs was to discuss with other panel chairs in order to adopt a broadly similar 
approach. The panel chairs and vice-chairs had a pre-meeting on 27 May 2011 in Amsterdam. 
The panel compositions were nominated by the Rector of the University 27 April 2011. The participating 
RCs suggested the panel members. The total number of panel members was 50. The reason for a smaller 
number of panellists as compared to the previous evaluations was the character of the evaluation as a 
meta-evaluation. The panellists did not read research reports or abstracts but instead, they evaluated 
answers to the evaluation questions, tables and compilations of publications, other scientific activities, 
bibliometrics and comparable analyses. 
 
The panel meetings were held in Helsinki: 
 On 11–13 September 2011: (1) biological, agricultural and veterinary sciences, (2) medicine, 
biomedicine and health sciences and (3) natural sciences.  
 On 18–20 September 2011: (4) humanities and (5) social sciences. 
  
                                                                
3 TUHAT (acronym) of Research Information System (RIS) of the University of Helsinki 
4 Supervision of thesis, prizes and awards, editorial work and peer reviews, participation in committees, boards and 
networks and public appearances. 
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1.5 Evaluation material 
The main material in the evaluation was the RCs’ self-evaluations that were qualitative in character and 
allowed the RCs to choose what was important to mention or emphasise and what was left unmentioned. 
The present evaluation is exceptional at least in the Finnish context because it is based on both the 
evaluation documentation (self-evaluation questions, publications and other scientific activities) and the 
bibliometric reports. All documents were delivered to the panellists for examination. 
Traditional bibliometrics can be reasonably done mainly in medicine, biosciences and natural sciences 
when using the Web of Science database, for example. Bibliometrics, provided by CWTS/The Centre for 
Science and Technology Studies, University of Leiden, cover only the publications that include WoS 
identification in the TUHAT-RIS. 
Traditional bibliometrics are seldom relevant in humanities and social sciences because the 
international comparable databases do not store every type of high quality research publications, such as 
books and monographs and scientific journals in other languages than English. The Helsinki University 
Library has done analysis to the RCs, if their publications were not well represented in the Web of Science 
databases (RCs should have at least 50 publications and internal coverage of publications more than 40%) 
– it meant 58 RCs. The bibliometric material for the evaluation panels was available in June 2011. The RC-
specific bibliometric reports are attached at the end of each report. 
The panels were provided with the evaluation material and all other necessary background information, 
such as the basic information about the University of Helsinki and the Finnish higher education system. 
 
Evaluation material 
1. Registration documents of the RCs for the background information 
2. Self evaluation material – answers to the evaluation questions 
3. Publications and other scientific activities based on the TUHAT RIS: 
3.1. statistics of publications 
3.2. list of publications 
3.3. statistics of other scientific activities 
3.4. list of other scientific activities 
4. Bibliometrics and comparable analyses: 
4.1. Analyses of publications based on the verification of TUHAT-RIS publications with the Web 
of Science publications (CWTS/University of Leiden) 
4.2. Publication statistics analysed by the Helsinki University Library - mainly for humanities and 
social sciences 
5. University level survey on doctoral training (August 2011) 
6. University level analysis on publications 2005–2010 (August 2011) provided by CWTS/University 
of Leiden 
 
Background material 
 
University of Helsinki 
- Basic information about the University of the Helsinki 
- The structure of doctoral training at the University of Helsinki 
- Previous evaluations of research at the University of Helsinki – links to the reports: 1998 and 2005 
 
The Finnish Universities/Research Institutes 
- Finnish University system 
- Evaluation of the Finnish National Innovation System 
- The State and Quality of Scientific Research in Finland. Publication of the Academy of Finland 
9/09. 
 
The evaluation panels were provided also with other relevant material on request before the meetings in 
Helsinki. 
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1.6 Evaluation questions and material 
The participating RCs answered the following evaluation questions which are presented according to the 
evaluation form. In addition, TUHAT RIS was used to provide the additional material as explained. For 
giving the feedback to the RCs, the panellists received the evaluation feedback form constructed in line 
with the evaluation questions: 
 
1. Focus and quality of the RC’s research 
 Description of 
- the RC’s research focus. 
- the quality of the RC’s research (incl. key research questions and results) 
- the scientific significance of the RC’s research in the research field(s) 
 Identification of the ways to strengthen the focus and improve the quality of the RC’s research 
The additional material: TUHAT compilation of the RC’s publications, analysis of the RC’s publications data 
(provided by University of Leiden and the Helsinki University Library) 
A written feedback from the aspects of: scientific quality, scientific significance, societal impact, 
innovativeness 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
2. Practises and quality of doctoral training 
 Organising of the doctoral training in the RC. Description of the RC’s principles for: 
- recruitment and selection of doctoral candidates 
- supervision of doctoral candidates 
- collaboration with faculties, departments/institutes, and potential graduate schools/doctoral 
programmes 
- good practises and quality assurance in doctoral training 
- assuring of good career perspectives for the doctoral candidates/fresh doctorates 
 Identification of the RC’s strengths and challenges related to the practises and quality of doctoral 
training, and the actions planned for their development. 
The additional material: TUHAT compilation of the RC’s other scientific activities/supervision of doctoral 
dissertations 
A written feedback from the aspects of: processes and good practices related to leadership and 
management 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
3. The societal impact of research and doctoral training 
 Description on how the RC interacts with and contributes to the society (collaboration with 
public, private and/or 3rd sector). 
 Identification of the ways to strengthen the societal impact of the RC’s research and doctoral 
training. 
The additional material: TUHAT compilation of the RC’s other scientific activities. 
A written feedback from the aspects of: societal impact, national and international collaboration, 
innovativeness 
 
  Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
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4. International and national (incl. intersectoral) research collaboration and researcher mobility 
 Description of  
- the RC’s research collaborations and joint doctoral training activities 
- how the RC has promoted researcher mobility 
 Identification of the RC’s strengths and challenges related to research collaboration and 
researcher mobility, and the actions planned for their development. 
A written feedback from the aspects of: scientific quality, national and international collaboration 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
5. Operational conditions  
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties). 
 Identification of the RC’s strengths and challenges related to operational conditions, and the 
actions planned for their development. 
A written feedback from the aspects of: processes and good practices related to leadership and 
management 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
6. Leadership and management in the researcher community 
 Description of 
- the execution and processes of leadership in the RC 
- how the management-related responsibilities and roles are distributed in the RC 
- how the leadership- and management-related processes support 
- high quality research 
- collaboration between principal investigators and other researchers in the RC 
the RC’s research focus 
- strengthening of the RC’s know-how 
 Identification of the RC’s strengths and challenges related to leadership and management, and 
the actions planned for developing the processes 
 
7. External competitive funding of the RC 
 The RCs were asked to provide information of such external competitive funding, where: 
- the funding decisions have been made during 1.1.2005-31.12.2010, and 
- the administrator of the funding is/has been the University of Helsinki 
 On the e-form the RCs were asked to provide: 
1) The relevant funding source(s) from a given list (Academy of Finland/Research Council, TEKES/The 
Finnish Funding Agency for Technology and Innovation , EU, ERC, foundations, other national funding 
organisations, other international funding organisations), and 
2)The total sum of funding which the organisation in question had decided to allocate to the RCs 
members during 1.1.2005–31.12.2010. 
 
Competitive funding reported in the text is also to be considered when evaluating this point. 
A written feedback from the aspects of: scientific quality, scientific significance, societal impact, 
innovativeness, future significance 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
8. The RC’s strategic action plan for 2011–2013 
 RC’s description of their future perspectives in relation to research and doctoral training. 
A written feedback from the aspects of: scientific quality, scientific significance, societal Impact, processes 
and good practices related to leadership and management, national and international collaboration, 
innovativeness, future significance 
 Strengths 
 Areas of development 
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 Other remarks 
 Recommendations 
 
9. Evaluation of the category of the RC in the context of entity of the evaluation material (1-8) 
 
The RC’s fitness to the chosen participation category 
A written feedback evaluating the RC’s fitness to the chosen participation category  
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
10. Short description of how the RC members contributed the compilation of the stage 2 material 
Comments on the compilation of evaluation material 
 
11. How the UH’s focus areas are presented in the RC’s research? 
Comments if applicable 
 
12. RC-specific main recommendations based on the previous questions 1–11 
 
13. RC-specific conclusions 
1.7 Evaluation criteria 
The panellists were expected to give evaluative and analytical feedback to each evaluation question 
according to their aspects in order to describe and justify the quality of the submitted material. In 
addition, the evaluation feedback was asked to be pointed out the level of the performance according to 
the following classifications: 
 outstanding  (5) 
 excellent  (4) 
 very good  (3) 
 good   (2) 
 sufficient  (1) 
 
Evaluation according to the criteria was to be made with thorough consideration of the entire 
evaluation material of the RC in question. Finally, in questions 1-4 and 9, the panellists were expected to 
classify their written feedback into one of the provided levels (the levels included respective descriptions, 
‘criteria’). Some panels used decimals in marks. The descriptive level was interpreted according to the 
integers and not rounding up the decimals by the editors. 
 
Description of criteria levels 
Question 1 – FOCUS AND QUALITY OF THE RC’S RESEARCH 
 
Classification: Criteria (level of procedures and results) 
Outstanding quality of procedures and results (5) 
Outstandingly strong research, also from international perspective. Attracts great international 
interest with a wide impact, including publications in leading journals and/or monographs published 
by leading international publishing houses. The research has world leading qualities. The research 
focus, key research questions scientific significance, societal impact and innovativeness are of 
outstanding quality. 
In cases where the research is of a national character and, in the judgement of the evaluators, should 
remain so, the concepts of ”international attention” or ”international impact” etc. in the grading 
criteria above may be replaced by ”international comparability”. 
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Operations and procedures are of outstanding quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are in 
alignment with the documentation. The ambition to develop the community together is of 
outstanding quality. 
Excellent quality of procedures and results (4) 
Research of excellent quality. Typically published with great impact, also internationally. Without 
doubt, the research has a leading position in its field in Finland. 
Operations and procedures are of excellent quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are to 
large extent in alignment with the documentation. The ambition to develop the community together 
is of excellent quality. 
Very good quality of procedures and results (3) 
The research is of such very good quality that it attracts wide national and international attention. 
Operations and procedures are of very good quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are to 
large extent in alignment with the documentation. The ambition to develop the community together 
is of very good quality. 
Good quality of procedures and results (2) 
Good research attracting mainly national attention but possessing international potential, 
extraordinarily high relevance may motivate good research. 
Operations and procedures are of good quality, shared occasionally in the community. The 
improvement of research and other efforts are occasionally documented and operations and 
practices are to large extent in alignment with the documentation. The ambition to develop the 
community together is of good quality. 
Sufficient quality of procedures and results (1) 
In some cases the research is insufficient and reports do not gain wide circulation or do not have 
national or international attention. Research activities should be revised. 
Operations and procedures are of sufficient quality, shared occasionally in the community. The 
improvement of research and other efforts are occasionally documented and operations and 
practices are to some extent in alignment with the documentation. The ambition to develop the 
community together is of sufficient quality. 
 
Question 2 – DOCTORAL TRAINING 
Question 3 – SOCIETAL IMPACT 
Question 4 – COLLABORATION 
 
Classification: Criteria (level of procedures and results) 
Outstanding quality of procedures and results (5) 
Procedures are of outstanding quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are in alignment with the 
documentation. The ambition to develop the community together is of outstanding quality. The 
procedures and results are regularly evaluated and the feedback has an effect on the planning. 
Excellent quality of procedures and results (4) 
Procedures are of excellent quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of excellent quality. The 
procedures and outcomes are evaluated and the feedback has an effect on the planning. 
Very good quality of procedures and results (3) 
Procedures are of very good quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
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management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of very good quality. 
Good quality of procedures and results (2) 
Procedures are of good quality, shared occasionally in the community. The practices and quality of 
doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of good quality. 
Sufficient quality of procedures and results (1) 
Procedures are of sufficient quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are occasionally documented and operations and practices are to some extent in 
alignment with the documentation. The ambition to develop the community together is of sufficient 
quality. 
 
Question 9 – CATEGORY 
Participation category – fitness for the category chosen 
The choice and justification for the chosen category below should be reflected in the RC’s responses to the 
evaluation questions 1–8. 
1. The research of the participating community represents the international cutting edge in its field. 
2. The research of the participating community is of high quality, but the community in its present 
composition has yet to achieve strong international recognition or a clear break-through. 
3. The research of the participating community is distinct from mainstream research, and the special 
features of the research tradition in the field must be considered in the evaluation. The research is 
of high quality and has great significance and impact in its field. However, the generally used 
research evaluation methods do not necessarily shed sufficient light on the merits of the 
research.  
4. The research of the participating community represents an innovative opening. A new opening can 
be an innovative combination of research fields, or it can be proven to have a special social, 
national or international demand or other significance. Even if the researcher community in its 
present composition has yet to obtain proof of international success, its members can produce 
convincing evidence of the high level of their previous research. 
5. The research of the participating community has a highly significant societal impact. The 
participating researcher community is able to justify the high social significance of its research. 
The research may relate to national legislation, media visibility or participation in social debate, 
or other activities promoting social development and human welfare. In addition to having 
societal impact, the research must be of a high standard. 
 
An example of outstanding fitness for category choice (5) 5 
The RC’s representation and argumentation for the chosen category were convincing. The RC recognized 
its real capacity and apparent outcomes in a wider context to the research communities. The specific 
character of the RC was well-recognized and well stated in the responses. The RC fitted optimally for the 
category. 
 
 Outstanding  (5) 
 Excellent  (4) 
 Very good  (3) 
 Good   (2) 
 Sufficient  (1) 
The above-mentioned definition of outstanding was only an example in order to assist the panellists in 
the positioning of the classification. There was no exact definition for the category fitness. 
                                                                
5 The panels discussed the category fitness and made the final conclusions of the interpretation of it. 
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1.8 Timetable of the evaluation 
The main timetable of the evaluation: 
1. Registration   November 2010 
2. Submission of self-evaluation materials  January–February 2011 
3. External peer review    May–September 2011 
4. Published reports    March–April 2012 
- University level public report 
- RC specific reports 
 
The entire evaluation was implemented during the university’s strategy period 2010–2012. The preliminary 
results were available for the planning of the following strategy period in late autumn 2011. The evaluation 
reports will be published in March/April 2012. More detailed time schedule is published in the University 
report. 
1.9 Evaluation feedback – consensus of the entire panel 
The panellists evaluated all the RC-specific material before the meetings in Helsinki and mailed the 
draft reports to the evaluation office. The latest interim versions were on-line available to all the panellists 
on the Wiki-sites. In September 2011, in Helsinki the panels discussed the material, revised the first draft 
reports and decided the final numeric evaluation. After the meetings in Helsinki, the panels continued 
working and finalised the reports before the end of November 2011. The final RC-specific reports are the 
consensus of the entire panel. 
The evaluation reports were written by the panels independently. During the editing process, the 
evaluation office requested some clarifications from the panels when necessary. The tone and style in the 
reports were not harmonized in the editing process. All the reports follow the original texts written by the 
panels as far as it was possible. 
The original evaluation material of the RCs, provided for the panellists is attached at the end of the 
report. It is essential to notice that the exported lists of publications and other scientific activities depend 
how the data was stored in the TUHAT-RIS by the RCs. 
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2 Evaluation feedback 
2.1 Focus and quality of the RC’s research 
 Description of 
 the RC’s research focus 
 the quality of the RC’s research (incl. key research questions and results) 
 the scientific significance of the RC’s research in the research field(s) 
 Identification of the ways to strengthen the focus and improve the quality of the RC’s research 
ASPECTS: Scientific quality, scientific significance, societal impact, innovativeness 
 
This community comprises eight individual groups. It has an interesting history. The nucleus is a 
collaborative program set up by Wartiovaara, Tienari and Lindsberg, followed by recruitment from abroad 
of two new group leaders, Hovatta and Battersby all focusing on neurologic/neuropsychiatric disorders. 
Complementary recruitments of two experts in mitochrondrial medicine (Tyni and Eriksson) and finally 
Otonkoski, stem cell biology has completed the group with four more senior PIs and four junior. The new 
recruitments have apparently been successfully integrated, although overlapping with the 
neurologic/psychiatric issues is not always prominent. The diversity is to an extent beneficial but by 
experience integration is a slow process in a competitive landscape. 
The focus area is explicitly stated as clinical science, although most of the work is on cells or in animal 
models. The dominant foci are on mitochondrial dynamics, proteases, oxidation defects/dysfunction in 
human disorders (4 groups: Battersby, Eriksson, Tyni, Wartioovara), complemented by a rather wide 
spectrum of research involving genetic regulation of psychiatric disorders (Hovatta), pathophysiology of 
cerebrovascular diseases (Lindsberg), cell biology of stem cells related to beta-cell biology and diabetes 
(Otonkoski), genetics of neurodegenration/demyelination (Tienari). The initiative to bring in the Stem Cell 
Unit into the program should receive special attention since isolation of fibroblasts from patients is 
becoming a valuable asset in identification of biomarkers. Complementation of the group through 
recruitment of foreign scientists is an important step since inbreeding is clearly negative. 
The overall publication output of MNRP is excellent, given the recent establishment of most of the 
groups and the size of the RC. There is an average of around 40 publications/year, with a vast majority 
(>50%) in very good journals (IF>5) of molecular neuroscience/neurology/neurogenetics, high-lighted by 
11 papers in top rank journals (Nature/clones, PLoS Med, Lancet Neurol). It is evident that some of the high 
rank papers result from pre-RC work of the members and/or from collaborative approaches. It can be 
foreseen that this high quality research can be maintained in the current excellent research environment 
and thereby contribute to development of this RC into one of high international visibility. 
The RC has the potential and willingness to provide a strong basis for translational research. 
Unfortunately, it is unclear to what extent scientists in the program have a clinical background. The 
reported low and even lessening interest in research at the clinical departments is a worrying 
phenomenon. We suggest joint discussions with the academic and health care providers to strengthen the 
links. Finland should have ideal possibilities for translational research and we strongly encourage 
rectification of what seems a missing opportunity. 
Numeric evaluation: 4 (Excellent) 
2.2 Practises and quality of doctoral training 
 Organising of the doctoral training in the RC. Description of the RC’s principles for: 
 recruitment and selection of doctoral candidates 
 supervision of doctoral candidates 
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 collaboration with faculties, departments/institutes, and potential graduate schools/doctoral 
programmes 
 good practises and quality assurance in doctoral training 
 assuring of good career perspectives for the doctoral candidates/fresh doctorates 
 Identification of the RC’s strengths and challenges related to the practises and quality of doctoral 
training, and the actions planned for their development. 
 Additional material: TUHAT compilation of the RC’s other scientific activities/supervision of doctoral 
dissertations 
ASPECTS: Processes and good practices related to leadership and management 
 
The recruitment of students seems to work well and their commitment is thriving in the interactive 
environment. It is, however, not clear how many students have an MD or at least some medical 
background, and whether those who are in clinical practice get undisturbed time for research. In addition, 
existence of a dedicated, structured PhD or MD-PhD program (i.e. Molecular Neurology) with certified 
program elements (credit points) is not clear from the information provided. 
Recruitment of “the best” students seem to be hampered by lack of career options and high 
administrative burden. These points should be rectified. 
Numeric evaluation: 4 (Excellent) 
2.3 The societal impact of research and doctoral training 
 Description on how the RC interacts with and contributes to the society (collaboration with public, 
private and/or 3rd sector). 
 Identification of the ways to strengthen the societal impact of the RC’s research and doctoral training. 
 Additional material: TUHAT compilation of the RC’s other scientific activities. 
ASPECTS: Societal impact, national and international collaboration, innovativeness 
 
The RC has been very active in popularizing science. The program runs several meetings directed to the 
general public. Staff contributes to periodicals directed to the medical community and interest groups 
(physicians and patients organizations) with information on research news. This is an excellent example on 
how scientific matters are popularized. Website? 
Numeric evaluation: 4 (Excellent) 
2.4 International and national (incl. intersectoral) research 
collaboration and researcher mobility 
 Description of  
 the RC’s research collaborations and joint doctoral training activities 
 how the RC has promoted researcher mobility 
 Identification of the RC’s strengths and challenges related to research collaboration and researcher 
mobility, and the actions planned for their development. 
ASPECTS: Scientific quality, national and international collaboration 
 
This program has shown foresight in recruitments that have enriched the knowledge base. This is highly 
commendable and should be encouraged, for instance with contacts with the foreign research arenas. A 
valuable resource for increasing international input is the homecoming scientists who after several years 
(successful) post doc master new technologies and bring home contacts. We notice the difficulties of 
supporting young scientists and we emphasize the duty of university to keep these valuable recruits to 
faculty. Homecomers should be given the chance to start their own projects and not return to the safe 
haven of their former supervisors. 
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The RC is highly networked nationally and internationally, indicated by a high number of publications 
from collaborations, participation to several EU networks (SAVEBETA, ESTOOLS, LIV-ES, SYSGENET 
COSAT), and NIH and ALS funding. 
Numeric evaluation: 4 (Excellent) 
2.5 Operational conditions 
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties). 
 Identification of the RC’s strengths and challenges related to operational conditions, and the actions 
planned for their development. 
ASPECTS: Processes and good practices related to leadership and management 
 
It is stated explicitly that each PI has full academic freedom to conduct a research program. This may seem 
an ideal situation but with the spectacular advances in basic sciences, the rising costs for research, and the 
complexity of the diseases/pathologies under study, a closed door (“silo”) is not realistic for survival. 
Again it should be emphasized that translational research requires both excellence in basic science and 
excellence in the clinical characterization (diagnosis) and therapy selection. The goal of translational 
research is personalized medicine, and with such mission, the health care providers would resonance with 
approval. 
Increasing clinical duties, administrative burden, and decreasing funds for research deserve special 
attention by HU. 
Defined time should be set aside to discuss goals and means. 
2.6 Leadership and management in the researcher community 
 Description of  
 the execution and processes of leadership in the RC 
 how the management-related responsibilities and roles are distributed in the RC 
 how the leadership- and management-related processes support 
 high quality research 
 collaboration between principal investigators and other researchers in the RC 
 the RC’s research focus 
 strengthening of the RC’s know-how 
 Identification of the RC’s strengths and challenges related to leadership and management, and the 
actions planned for developing the processes 
ASPECTS: Processes and good practices related to leadership and management 
 
The leadership has successfully recruited talented young researchers and achieved a program structure 
with a broad and competent knowledge base. In the broad and varied field of research, it will be difficult 
to maintain excellence in all areas. We recommend a scientist in residence arrangement to allow visiting 
scientists spending a few weeks to a month lecturing and tutoring the junior staff and graduate students. 
2.7 External competitive funding of the RC 
• The RCs were asked to provide information of such external competitive funding, where: 
• the funding decisions have been made during 1.1.2005–31.12.2010, and  
• the administrator of the funding is/has been the University of Helsinki 
• On the e-form the RCs were asked to provide: 
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1) The relevant funding source(s) from a given list (Academy of Finland/Research Council, 
TEKES/The Finnish Funding Agency for Technology and Innovation, EU, ERC, foundations, other 
national funding organisations, other international funding organizations), and 
2) The total sum of funding which the organisation in question had decided to allocate to the RCs 
members during 1.1.2005–31.12.2010. 
Competitive funding reported in the text is also to be considered when evaluating this point. 
ASPECTS: Scientific quality, scientific significance, societal impact, innovativeness and future significance 
 
Funding is reported to be very good according to national standards. The problem of recruiting excellent 
junior scientists without tenure-track options requires attention by HU. 
2.8 The RC’s strategic action plan for 2011–2013 
• RC’s description of their future perspectives in relation to research and doctoral training. 
ASPECTS: Scientific quality, scientific significance, societal Impact, processes and good practices related to 
leadership and management, national and international collaboration, innovativeness, future significance 
 
The proposal for the next budget period is very superficial and cannot be evaluated – “driven by science 
questions”. Apparently, no new initiatives are planned or investments/new contacts. 
The strong support for tenure-track positions for young investigators is commendable. 
The requirement for MD-PIs in clinically oriented research seems a conditio-sine-qua-non. This point 
needs to be discussed in detail. 
2.9 Evaluation of the category of the RC in the context of entity of 
the evaluation material (1-8) 
The RC’s fitness to the chosen participation category. 
Category 1. The research of the participating community represents the international cutting edge in its field. 
 
The MNRP strengths lie in a strategy to recruit state-of-the-art technologies in cell biology/biotechnology 
enabling identification of genetic and molecular bases of pathologies related to neurologic/psychiatric 
diseases. Consequences of this strategy are individual research groups of high quality with a wealth of 
international connections, and a potentially high societal impact of their research. The spectrum of 
scientific topics is rather broad, and the overall focus is on mechanistic rather than clinical levels of 
research. This marks a most promising basis for a convergent scientific strategy that will certainly move 
this RC towards one of highest international standing. For the time being, assignment of the RC to 
category 2 or 4 might have been a more adequate choice. 
Numeric evaluation: 4 (Excellent) 
2.10 Short description of how the RC members contributed the 
compilation of the stage 2 material 
The processes employed were fair and appropriate. The reviewers have been impressed by the very clear 
distinctive description of strengths and challenges. 
 
 
 
 
 
19 
 
2.11 How the UH’s focus areas are presented in the RC’s research 
Focus area 6: Clinical research 
 
The RC is strongly devoted to basic research, with high translational potential. Bedside to bench is a 
clearly visible research direction of the RC, with efforts near exclusively on the bench level. Therefore the 
focus will fit well with “the basic structure of life”, and the link with “clinical science” seems one that can 
be developed. 
2.12 RC-specific main recommendations 
The single most important recommendation is to develop a common theme and strategy for translational 
research. 
2.13 RC-specific conclusions 
The strengths of this RC lie in a strategy to recruit state-of-the-art technologies in cell 
biology/biotechnology enabling identification of genetic and molecular bases of pathologies related to 
neurologic/psychiatric diseases. One consequence of this strategy are individual research groups of high 
quality with international connections, but a rather diverse spectrum of scientific topics, and a focus on the 
mechanistic rather than the clinical level of research. On the other hand this provides a most promising 
basis for development of this RC towards one of highest international standing. 
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3 Appendices 
A. Original evaluation material 
a. Registration material – Stage 1 
b. Answers to evaluation questions – Stage 2 
c. List of publications 
d. List of other scientific activities 
B. Bibliometric analyses 
a. Analysis provided by CWTS/University of Leiden 
b. Analysis provided by Helsinki University Library (66 RCs) 
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         RC-SPECIFIC MATERIAL FOR THE PEER REVIEW 
 
 
 
 
NAME OF THE RESEARCHER COMMUNITY:  
Research Program of Molecular Neurology (MNRP) 
 
LEADER OF THE RESEARCHER COMMUNITY:  
Professor Anu Wartiovaara, Molecular neurology research Program, Research Program Unit, 
Faculty of Medicine 
 
RC-SPECIFIC MATERIAL FOR THE PEER REVIEW: 
 Material submitted by the RC at stages 1 and 2 of the evaluation 
- STAGE 1 material: RC’s registration form (incl. list of RC participants in an excel table) 
- STAGE 2 material: RC’s answers to evaluation questions 
 TUHAT compilations of the RC members’ publications 1.1.2005-31.12.2010 
 TUHAT compilations of the RC members’ other scientific activities 1.1.2005-31.12.2010 
 Web of Science(WoS)-based bibliometrics of the RC’s publications data 1.1.2005-31.12.2010 
(analysis carried out by CWTS, Leiden University) 
NB! Since Web of Science(WoS)-based bibliometrics does not provide representative results for most RCs representing 
humanities, social sciences and computer sciences, the publications of these RCs will be analyzed by the UH Library 
(results available by the end of June, 2011) 
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INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
 
 
Name: Wartiovaara, Anu 
E-mail:  
Phone: +358 9 4717 1965 
Affiliation: Faculty of Medicine, Research Program Unit, Biomedicum-Helsinki 
Street address: Haartmaninkatu 8 
 
 
Name of the participating RC (max. 30 characters): Research Program of Molecular Neurology 
Acronym for the participating RC (max. 10 characters): MNRP 
Description of the operational basis in 2005-2010 (eg. research collaboration, joint doctoral training 
activities) on which the RC was formed (MAX. 2200 characters with spaces): Molecular Neurology 
Research Program is a research unit of Faculty of Medicine, selected to be part of the research program 
unit in a competitive call for 2007-2012. MNRP consists of eight research groups, all interested in molecular 
basis of human diseases, with special emphasis on neurological disorders and energy metabolism. We form 
a unit with common research interest, shared unique materials, shared equipment, close collaboration, 
common seminar series and student training. Our synergy is based on complementing expertise, combining 
clinical experience to high quality molecular medicine and disease models. The aim of the unit is to exploit 
our scientific findings to benefit patient care, both diagnosis and treatment. 
 
 
Main scientific field of the RC’s research: medicine, biomedicine and healt sciences 
RC's scientific subfield 1: Medicine, Research and Experimental 
RC's scientific subfield 2: Clinical Neurology 
RC's scientific subfield 3: Cell Biology 
RC's scientific subfield 4: Neurosciences 
Other, if not in the list: Mitochondrial medicine 
Stem cell biology 
 
 
Participation category: 1. Research of the participating community represents the international cutting 
edge in its field 
Justification for the selected participation category (MAX. 2200 characters with spaces):  The research 
program unit of Molecular Neurology, consisting of eight group leaders, combines the expertise of clinical 
1 RESPONSIBLE PERSON 
2 DESCRIPTION OF THE PARTICIPATING RESEARCHER COMMUNITY (RC) 
3 SCIENTIFIC FIELDS OF THE RC 
4 RC'S PARTICIPATION CATEGORY 
 
 
2 
 
INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
and molecular medicine to basic biology. These group leaders are in different career stages, including 
internationally recognized senior PI's and group leaders of early-career-phase but excellent publication 
record. Two groups are part of Finnish Centre of Excellence for Mitochondrial Disease and Aging of the 
Academy of Finland. The common interest in molecular pathogenesis of neurological disease, with special 
emphasis on mitochondrial disorders, combined with excellent clinical materials, unique disease models, 
both clinical and molecular expertise, international collaboration networks, and excellent scientific 
publication and training record, justify the participation category 1. 
 
 
Public description of the RC's research and doctoral training (MAX. 2200 characters with spaces): The 
Research Program of Molecular Neurology is one of the six Research Programs of the Faculty of Medicine, 
Helsinki University, for 2007 - 2012.  Our program's ambitious mission is to clarify disease mechanisms 
underlying neurological and neuropsychiatric diseases. Our strong expertise in basic research enables us to 
search for disease and susceptibility genes, and to study the disease mechanisms in cultured cells, disease 
models and in patients and their tissues. By gaining knowledge on the molecular disease processes, we gain 
tools to search for drugs and chemical compounds that could slow down or affect these diseases.  Further, 
this knowledge is utilized in patient counseling, for information on risk factors. The direct links of our 
program to child and adult neurology clinics enable effective translation of research knowledge to benefit 
the diagnosis and treatment of the patients. The program is closely connected to the graduate schools of 
the campus, and is active in doctoral training, with currently over 30 PhD projects undergoing. The program 
organizes common science days, lecture series and training courses on the topics of its interest. 
Significance of the RC's research and doctoral training for the University of Helsinki (MAX. 2200 
characters with spaces): The MNRP consists of one Centre of Excellence of the Academy of Finland (FinMIT) 
and the whole program was evaluated and selected based on its quality of science as a Research Program 
of Faculty of Medicine, 2007-2012. The groups produce tens of high profile scientific publications yearly, 
with important implications to medical care and biological knowledge. MNRP is closely connected to the 
graduate schools of the campus, and is active in doctoral training, with currently over 30 PhD projects 
undergoing. 10 completed PhD thesis works have been produced by the program during 2005-2010. The 
program organizes common science days, lecture series and training courses on the topics of its interest. 
Keywords: Mitochondrial disease, mitochondrial function, neurodegeneration, stem cells, metabolic 
disease, stroke, inherited diseases, neuropsychiatry 
 
 
Justified estimate of the quality of the RC's research and doctoral training at national and international 
level during 2005-2010 (MAX. 2200 characters with spaces): MNRP consists of eight research groups, in 
different stages of career. Four group leaders are established, internationally recognized scientists, of 
which one belongs to FinMIT centre of excellence in science. Their publication record indicates excellence, 
and their success can also be seen in the amount of national and international competitive funding 
attracted (for 2010 over 3M €; including EU-FP7, new ERC. Four groups are in a more initial phase, and even 
their publication record has been excellent. The vision of the program is to foster young promising group 
leaders and support their independence within the strong program structure, research culture and 
5 DESCRIPTION OF THE RC'S RESEARCH AND DOCTORAL TRAINING 
6 QUALITY OF RC'S RESEARCH AND DOCTORAL TRAINING 
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environment. MNRP groups together have supervised 10 completed PhD theses during 2005, with ~30 
undergoing, being active in doctoral training. Four of the thesis works were approved with distinction 
(given to less than 10% of Faculty's theses) and attracted 5 thesis awards. We are convinced that the 
research done in our unit meets all international standards and we aim to highest quality pioneering-type 
of research in the field of molecular medicine. 
Comments on how the RC's scientific productivity and doctoral training should be evaluated (MAX. 2200 
characters with spaces): We suggest the Unit to be evaluated based on the quality of our publications, 
success in attracting external funding, clinical and biological relevance of our scientific results, translational 
value, i.e. bridging of basic science to clinical bed side and transfer of results to benefit clinical work, 
international and national networking, quality of doctoral thesis works. Our publishing strategy is active: we 
publish our original research findings in international scientific  journals of high profile, and frequently also 
write reviews on topics of our area of expertise.  Summaries of important findings, commentaries and 
reviews are also published as short informative summaries in national medical journals. Most PIs contribute 
to book chapters from their area of expertise. Publication policy is very active. Some of our PI's participate 
in editorial boards of international journals, indicating international recognition. 
LIST OF RC MEMBERS
NAME OF THE RESEARCHER COMMUNITY: Molecular Neurology Research Program (MNRP), Faculty of Medicine, Biomedicum-Helsinki, University of Helsinki
RC-LEADER A. Wartiovaara
CATEGORY 1
Last name First name
PI-status 
(TUHAT, 
29.11.2010)
Title of research and 
teaching personnel Affiliation 
1 Wartiovaara Anu x
Professor, principal 
investigator
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
2 Lindsberg Perttu x
Professor, principal 
investigator
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
3 Otonkoski Timo x
Professor, principal 
investigator
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
4 Battersby Brendan x
Senior researcher, 
principal investigator
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
5 Tienari Pentti x
Senior researcher, 
principal investigator
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
6 Hovatta Iiris x
Senior researcher, 
principal investigator
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
7 Eriksson Ove x
Senior researcher, 
principal investigator
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
8 Tyni Tiina x
Senior researcher, 
principal investigator
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
9 Miettinen Päivi x senior researcher
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
10 Tuuri Timo senior researcher
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
11 Hyytiä Petri senior researcher
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
12 Richter Uwe postdoctoral researcher
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
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21 Bonetti Alessandro postdoctoral researcher
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
22 Carroll Christopher postdoctoral researcher
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
23 Euro Liliya postdoctoral researcher
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
24 Hakonen Anna postdoctoral researcher
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
25 Hämäläinen Riikka postdoctoral researcher
Faculty of Medicine, Research Program Unit, 
Molecular neurology research Program
26 Isohanni Pirjo postdoctoral researcher
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Name of the RC’s responsible person: Wartiovaara, Anu 
E-mail of the RC’s responsible person:   
Name and acronym of the participating RC: Molecular Neurology Research Program, MNRP 
The RC’s research represents the following key focus area of UH: 6. Kliininen tutkimus – Clinical research 
Comments for selecting/not selecting the key focus area: The focus area of MNRP fits with both 'Clinical 
research' and with 'the basic structure of life'. However, one of our main strengths is the combination 
expertise of clinical medicine and basic science in our research projects, to elucidate mechanisms of 
neurological and metabolic disease and to develop diagnosis and therapy. Therefore, even with MNRP's 
strong basic science base, the primary focus area of ours is clinical science. 
 
 
 Description of the RC’s research focus, the quality of the RC’s research (incl. key research 
questions and results) and the scientific significance of the RC’s research for the research 
field(s).  
Research focus 
The research focus of the Molecular Neurology Research Program (MNRP) is molecular mechanisms of 
neurological disorders, with a special emphasis on metabolism. Disorders of the nervous system are 
having an increasing impact in Western societies as the average lifespan is increasing, age being the 
biggest risk factor for neurodegeneration and stroke.  
MNRP research topics can be divided into four partially overlapping categories: 1. Molecular genetics of 
neurological and neuropsychiatric disease 2. Mitochondrial dysfunction and physiological consequences 
in disease 3. Hypoxia and ischemia of the nervous system, and mechanisms of neuroprotection  4. Stem 
cell biology and metabolism; applications to disease modelling. MNRP combines the wide clinical and 
basic science expertise of our groups to enhance research excellence and translate findings to benefit 
patients.  
MNRP has existed in the present group composition only from 2008. The groups of Wartiovaara, (AW), 
Tienari (PT) and Lindsberg (PL) formed the unit in 2005. In 2007, we were selected as a research 
program and able to recruit two excellent young group leaders: Iiris Hovatta (IH; Salk Institute, USA) and 
Brendan Battersby (BB; McGill University, Canada), who both had an excellent publication record (for 
example Hovatta et al. Nature 2005; Battersby et al. Nat Genet 2003 & 2007). At the same time, we 
strengthened the mitochondrial knowledge base by involving Tiina Tyni (TT), an expert of beta-
oxidation, and Ove Eriksson(OE), a mitochondrial biochemist, to the unit. In 2008, the raising importance 
of stem cell biology, especially the development of induced pluripotent stem cell techniques, motivated 
us to combine forces with Timo Otonkoski (TO) and the Biomedicum Stem Cell Centre, to utilize our 
patient-derived cell culture materials in generating human disease models. The first iPS lines and 
differentiated cell lines (cardiomyocytes, neurons, hepatocytes) have been established from 
mitochondrial disease and amyotrophic lateral sclerosis patient samples. 
 
The specific focus areas in 2005-2010 in individual research groups have been the following. Battersby: 
mechanisms of mitochondrial DNA segregation, mitochondrial biogenesis and dynamics. Eriksson: 
Mitochondrial proteases in cell death and their role in neuroprotection. Hovatta: Genetic regulation of 
normal and pathological anxiety and autism spectrum disorders. Lindsberg: The progression of acute 
BACKGROUND INFORMATION 
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ischemic neuronal injury, blood-brain-barrier damage and haemorrhage formation in the brain 
parenchyma and identification of novel targets for treatment of acute cerebrovascular disease. 
Otonkoski: Cell biology of human embryonic stem cells and human induced pluripotent stem cells (iPS), 
beta-cell biology and diabetes. Tienari: Genetics and epidemiology of neurodegeneration and 
demyelination. Tyni: The clinical features and pathogenetic mechanisms of mitochondrial fatty acid 
oxidation defects. Wartiovaara (Suomalainen in publications): Molecular basis of mitochondrial 
dysfunction in human disorders, development of diagnosis and therapy. 
 
Quality of research  
MNRP as a unit has published 183 original articles in international peer-reviewed journals during 2005-
2010, of which 91 (50%) were published in journals with an impact factor over 5. Eleven articles (6%) 
were published in top journals (Nature Biotechnol, Nature Methods, Nature Genet, Science Transl Med, 
PNAS, PLoS Med, Lancet Neurol). These bibliometric features indicate excellent quality of research. The 
highlights of our research 2005-2010 are as follows: 
- Development of mouse as an anxiety model (Hovatta et al. Nature 2005), and testing of those genetic 
variants in human populations (Donner et al Biol Psychiatry 2010) 
- Identification of two mutations (in chromosomes 9p21 and 21q/SOD1) explaining more than 70% of 
Finnish familial ALS cases (Laaksovirta et al Lancet Neurol 2010). 
- Cloning of a novel gene for progressive adult mitochondrial myopathy (Tyynismaa et al Am J Hum 
Genet 2009) 
- Identification of a novel form of pancreatic beta-cell dysregulation and characterization of its 
molecular basis (Otonkoski et al. Am J Hum Genet 2007).  
- Development of induced pluripotent stem cell technology (Närvä et al Nature Biotechnol 2010; 
International Stem Cell Initiative, Nature Biotechnol 2007).  
- Identification of several genetic loci contributing to the risk of multiple sclerosis (e.g. Jakkula et al Am J 
Hum Genet 2010). 
- Characterization of a universally conserved mitochondrial serine protease LACTB, as a potential 
polymerizing component of  mitoskeleton, a novel mitochondrial structure (Polianskyte et al PNAS 
2009).  
- Creation of the first animal model for late-onset mitochondrial dysfunction (Tyynismaa et al. PNAS 
2005), which was used for the first therapy trial for a true disease model (Ahola-Erkkilä et al. Hum Mol 
Genet 2010). These findings are being confirmed in humans, and the first therapy trial is initiated in 
patients. 
- Characterization of a mechanism how mtDNA variants segregate in a tissue-specific manner: 
identification of Gimap3, an outer mitochondrial membrane GTPase, as a regulator of mtDNA 
segregation in leukocytes (Jokinen et al PLoS Genet 2010) 
- Characterization of genetic basis of novel neurological disorders of childhood onset muscle dystrophy 
and progressive encephalopathy (Götz et al. Brain 2009; Hakonen et al. Brain 2008) 
- Multiple clinical studies on stroke therapy and management (Perttu Lindsberg’s publications, e.g. 
Mishra et al BMJ 2010).  
- Demonstration of  the role of perivascular mast cells in the acute reactive oedema during brain 
ischemia and its therapeutic implications (Strbian et al  J Cereb Blood Flow Metab 2007 ; Strbian et al 
Circulation 2007) 
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- Characterization of novel physiological consequences for mitochondrial DNA maintenance disorders, 
including a novel endocrine role for skeletal muscle (Ylikallio et al Hum Mol Genet 2010; Tyynismaa et 
al Hum Mol Genet 2010).  
- Characterisation of multiorgan dysfunction resulting from carnitine palmitoyltransferase deficiency 
(Roomets et al Neurology 2006).  
 
Scientific significance 
During 2005-2010 MNRP’s research has: (1) identified new molecular genetic basis for several 
mitochondrial disorders, multiple sclerosis, parkinsonism and ALS; (2)  developed novel therapeutic 
strategies for stroke and mitochondrial disorders; (3) discovered new molecular mechanisms in 
mitochondrial DNA maintenance, segregation and mitochondrial structure; (4) identified new clinical 
findings in neurological disorders; (5) developed novel animal models for anxiety and mitochondrial 
disorders; (6) established novel iPS cell culture models for research; (7) discovered novel physiological 
pathways in muscle degeneration and applied those findings  as diagnostic tools to HUSlab, the major 
diagnostic laboratory of the Helsinki University Central Hospital. As a consequence of our work, 
hundreds of patients have achieved a specific DNA-level diagnosis and genetic counselling, and 
therapies are being developed for currently incurable disorders.  Part of these achievements has been 
possible because of close collaborations within the RC, allowing sharing of valuable patient materials. 
These collaborations have resulted so far in 10 co-authored publications within the RC, the unit having 
existed only after 2007. However, grass-root level interaction, technology and knowledge sharing is 
active, which will lead to an increasing number of publications from joint MNRP projects. 
 Ways to strengthen the focus and improve the quality of the RC’s research. 
Individual research projects evolve based on scientific question. We do not wish to restrict further 
MNRP focus, but aim to support infrastructure to foster excellence. The current intellectual 
environment at MNRP and Biomedicum-Helsinki is good. However, some structural aspects could 
improve quality: 
- MNRP research is based solely on competitive grants, which typically are relatively small (<50,000 
€/year). Some shuttling of HU basic funding to research, based on evaluated excellence (e.g. this 
evaluation), would enable undertaking of long term, innovative, risky projects. MNRP has been quite 
successful in attracting funding from Finland and EU, but has to compete separately for space, posts 
and resources, which takes time away from science. 
- Currently, science is not attracting the best young people, because of lack of career paths. We 
welcome the new tenure-track system, but more such positions should be available. University 
positions for young PIs should be created (previous assistant professor), as many leave the country or 
academic science when relevant posts do not exist. 
 
 
  How is doctoral training organised in the RC? Description of the RC’s principles for recruitment and 
selection of doctoral candidates, supervision of doctoral candidates, collaboration with faculties, 
departments/institutes, and potential graduate schools/doctoral programmes, good practises and 
quality assurance in doctoral training, and assuring good career perspectives for the doctoral 
candidates/fresh doctorates.  
The principal goal of doctoral training within MNRP is to develop critical and analytical thinking skills of 
our students along with training in the latest scientific approaches in the field, which prepare them to 
solve complex scientific problems in biomedicine. Our students are recruited both domestically, from 
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the University of Helsinki and other Finnish Universities, as well as internationally, particularly Europe. 
Recruitment can be unsolicited or solicited by notices distributed through such sites as FinBioNet 
(http://www.biocenter.helsinki.fi/finbionet/) and Nature, and selection is based on detailed interview 
and evaluation by individual group leaders and their group members. Some of our students conduct 
their MSc research within our unit and then progress into PhD studies. The quality of students attracted 
and admitted to the laboratories within our RC is very high. Most of our students succeeded in the 
competitive application rounds for local graduate schools at the University of Helsinki, i.e. Helsinki 
Biomedical Graduate School (HBGS) and Graduate School in Biotechnology and Molecular Biology 
(GSBM) – indeed, 15 out of 24 PhD students of our RC are enrolled in a graduate school.  
Doctoral students are provided with intellectually challenging and ambitious research projects at the 
leading edge of our scientific disciplines. Supervision of the research project is overseen directly from 
the Principal Investigator and often, additional supervision is provided from a senior post-doctoral 
fellow within the laboratory. Our students have a follow-up or supervisory committee, which consists of 
two independent PIs that meet once a year to oversee the student’s research progress. Students are 
expected to present their research at regular laboratory meetings, at an annual program retreat, 
network meetings and at leading scientific meetings. We have a bi-weekly journal club and monthly 
meeting within the RC for students to present scientific papers from the most outstanding journals, in 
addition to every group’s own laboratory meetings. One of the PIs helps in the selection of scientific 
papers to encourage students to critically analyse the latest developments in biomedical research. These 
regular presentations ensure our students are effective communicators in science and English, which for 
most of the students is their second or third language. Most publications from the unit, including 
research project reports, MSc thesis or PhD thesis works, are written in English. Typically, the first draft 
of an article is written by the principal student. In order to defend the PhD thesis, students must follow 
the guidelines of the Faculty of Medicine, by publishing two to four first author papers, and one or two 
co-authored papers in high quality scientific journals. The supervisor and the follow-up/supervisory 
committee determine when the project is in mature state enough to write the thesis, and the final 
composition of the thesis is accepted by the Faculty. The PhD thesis standard in our unit is high – e.g. 
the best thesis of HBGS and the best thesis of the Faculty have been awarded in 2007 to our unit, as well 
as a special PhD award of Biomedicum-Helsinki Foundation in 2007.  
Overall, doctoral training within the RC provides students with the ability to properly develop and 
master skills in critical and analytical thinking, oral and written communication, and excellent technical 
training in biomedical research. This training and the outstanding publications in leading scientific 
journals will prepare and assure our students of solid career perspectives in science. We encourage 
postdoctoral period in a foreign laboratory, and our students are well positioned to get independent 
funding for postdoc visit from Foundations. Because of published original research articles,  required for 
Finnish thesis, typically students do not have difficulties in finding postdoctoral positions in major 
research centres. From 2005-2010, our former students have proceeded to postdocs e.g. in Yale 
University, University College London. Medical PhD students often proceed to clinical practice, but are 
supported in continuing in science as well.  Many continue part-time research along with their clinical 
duties. Our first ex-students have returned from foreign postdoc positions to Finland, and are applying 
tenure-track positions as independent group leaders. 
 RC’s strengths and challenges related to the practises and quality of doctoral training, and the actions 
planned for their development. 
Strengths: 
- Multidisciplinary science base: our 24 PhD students come from medicine, genetics, biology, 
bioinformatics, biotechnology and biochemistry. 
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- Versatile education: MNRP projects apply a wide variability of strategies and technologies, from 
leading-edge genomics to cell biology, animal models, behavioral testing, patient studies and protein 
biochemistry, offering opportunities to learn of various methods and skills.  
- Opportunities to present and report science: science days and seminar series organized to promote 
discussion and to teach science communication. 
- Active contribution in local graduate schools and their courses. 
- Follow-up-groups for PhD students, to support project progression. 
- Education on translation of science results to benefit patients. 
 
Challenges: 
- Recruitment of best students to research, due to lack of career options. MNRP strongly supports 
Faculty’s attempts to create tenure-track positions.  
- Administrative burden and labor-union involvement in PhD student career; the worker-attitude is not 
supportive for creative scientific research. 
 
 
 Description of how the RC interacts with and contributes to the society (collaboration with public, 
private and/or 3rd sector).  
MNRP is active in popularizing science. Our scientists, mostly the PIs, act as experts on the fields of 
neurodegeneration, stroke, mitochondrial disease, aging related degeneration, stem cell biology 
neuropsychiatry and genetics. Our several media appearances (TV, radio, magazines, newspapers) have 
been listed in the HU-TUHAT-database. We have successfully organized scientific symposia and utilized 
their speakers in public lectures, such as ‘Sigrid Jusélius Public Lectures on aging and nervous system 
aging’, with English-speaking leading experts on the topic, simultaneously translated in Finnish. These 
lectures attracted an actively discussing audience of over 500. Furthermore, we have contributed as 
speakers to Helsinki Science days (Tieteenpäivät), Brain awareness day, World Stroke day. Some of us 
are active writers: PT and PL report to Finnish physicians new developments in science in Duodecim-
journal, and AW serves as a regular science columnist in Finnish Journal for Physicians (Suomen 
Lääkärilehti) and University Journal (Yliopistolehti). Contributions as Editorials and review articles have 
been written by many to Finnish medical journals and newspapers (AW, PT, PL, IH, TO). TT serves as the 
chair of Metabolic Club, aimed in delivering knowledge on metabolic disorders to scientists and 
physicians. 
The physicians in our program work actively with patient organizations, to translate the new knowledge 
in the field to benefit the patients. For example, MS-union (PT), stroke-patient-union (PL), United 
Mitochondrial Disease Foundation (American patient organization; AW), Biking4energy (Dutch patient 
organization; AW) and Muscle disease union (AW). MNRP website has a patient-interface for 
mitochondrial disorder families and patients 
(http://research.med.helsinki.fi/neuro/Wartiovaara/index.htm), for frequently asked questions. PL has 
especially contributed to educate public of alarming initial stroke symptoms, and has been a driving 
force in affecting treatment strategies of stroke worldwide. For this contribution he was awarded the 
Scandinavian SalusAnsvar award in 2010.  
MNRP has been a key actor (PT, AW, TO) in generating multidisciplinary collaboration between the 
technical university Aalto, for bio- and nanotechnology development. Both ‘Neuro’-collaboration and 
‘Bionova’ networks have been established, and collaboration towards applied sciences has been 
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established. Our results, which have direct applications in medical use, are patented through Licentia-
company, partially owned by HU. Patent applications involve diagnosis of Parkinson’s disease and 
mitochondrial disease (AW, n=2), stroke treatment (PL, n=2). 
 Ways to strengthen the societal impact of the RC’s research and doctoral training. 
We consider science popularization and expert role in the society as our important tasks. We make a 
significant contribution in this era, and common programs with high schools have been planned, to 
enhance interest in biomedical sciences. However, we make our greatest effort and have our focus in 
innovative scientific research.  Our strong opinion is that innovations arise from non-restricted basic 
research – not necessarily from research that is now noted as translational -  as unexpected finding may 
have the largest relevance for human well being and health. Therefore, we strongly support HU funding 
tools for basic sciences, to enhance long-term continuous efforts to tackle molecular basis of disease 
and normal cellular function. 
 
 
 
 Description of the RC’s research collaborations and joint doctoral training activities and how the RC 
has promoted researcher mobility.  
The RC members participate actively in international and national collaborations and research networks. 
Collaboration within the RC is active and has so far resulted in 10 publications with authors from at least 
two research groups.  
Regarding national networks, two PIs (Wartiovaara and Battersby) belong to the Academy of Finland 
funded FinMIT centre of excellence in science (http://www.uta.fi/imt/finmit/), the other groups 
including Howy Jacobs and Hans Spelbrink from the Institute of Medical Technology of Tampere 
University, as well as ‘Academy Distinguished Prof’ Laurie Kaguni (Michigan State University). Because of 
the disease-oriented focus of our research, collaboration with the Helsinki University Central Hospital is 
essential, and PIs have had collaboration, leading to co-authored publications, with at least 12 different 
clinics.  Other national collaboration partners include research groups from University of Helsinki 
(Faculties of Medicine, Biological and Environmental Sciences, and Behavioral Sciences, Institutes of 
Biotechnology and Molecular Medicine), Universities of Oulu, Tampere, Eastern Finland and Turku, 
Seinäjoki  and Joensuu Central Hospitals, the Finnish Red Cross, VTT, and THL.  
 We have participated in several EU networks, including SAVEBETA 2006-2009 (T. Otonkoski), ESTOOLS 
2006-2010 (T. Otonkoski), LIV-ES  2008-2011 (T. Otonkoski),  and SYSGENET COST 2010-2013 (I. Hovatta) 
networks.  Other international joint research funding include Microsoft Research Foundation and 
American ALS Foundation funded project with NIH/ National Institute of Aging and University College 
London/ Institute of Neurology (P. Tienari) and The National MS Society of USA funded project with the 
Cambridge University and the International Multiple Sclerosis genetics consortium (P. Tienari), as well 
Finnish-Academy-funded research network between mitochondrial scientists in Japan and in Finland 
(FinMIT-Jmit), including yearly visits, conferences and collaboration. Altogether, the research program 
members had international collaboration, leading to co-authored publications, with more than 40 
Universities or Research Institutes. Several research projects were carried out with collaborators from 
Columbia University (New York, USA), Karolinska Institute (Stockholm, Sweden), Bergen University 
(Norway), Michigan State University (East Lansing, USA), Sheffield University (UK), McGill University 
(Montreal, Canada), and Max Planck Institute on Aging (Cologne, Germany).  
Research community’s joint doctoral training activities have included both seminars and research 
meetings. “NeuroDays” is a two day scientific meeting organized by the Research Program of Molecular 
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Neurology each year. In addition, we have organized “NeuroChat”, a monthly research seminar with 
internal and invited external speakers (2005-2008) and a weekly journal club (2009-2010) in which 
students and postdocs have presented important research articles from the field.  
Researcher mobility has been promoted by actively encouraging students to visit collaborating 
laboratories, to learn methodology and bring it to benefit the unit. These include e.g. visits to Karolinska 
Institute, University College London, NIH, Kyushu University (Japan) and Padova University (Italy). 
 RC’s strengths and challenges related to research collaboration and researcher mobility, and the 
actions planned for their development. 
Strengths: 
- RC is internationally and nationally highly networked, visualized by co-authored publications with over 
40 different research institutes during 2005-2010. 
- Fruitful collaboration with major national research centres and university hospitals. 
- PIs are recognized partners of international collaboration networks and in jointly funded projects, 
especially in EU and US. 
- Frequent researcher mobility as invited lectures and researcher exchange, for new methodology .  
- Because of generated highly interactive collaboration links, we can obtain required knowledge and 
methodology for basically any kind of science needs. 
- Collaborative links generated based on scientific questions, solidifying those links. 
 
Challenges: 
- no immediate challenges concerning research collaboration. 
 
 
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties).  
Biomedicum Helsinki (BMH) research institute hosts about 200 principal investigators of the UH and 
Helsinki University Central Hospital, providing excellent possibilities for the interaction and collaboration 
between clinical and basic scientists. The RC operates in the 5th floor of the BMH, dedicated to the 
Research Programs of the Faculty of Medicine.  This space is given for research programs for a fixed 
term (present term ad2012),  as a result of their competitive evaluation. MNRP is an excellent example 
of this, since our PIs represent both basic and clinical research, and apply basic research approaches for 
translational research.  
BMH provides an exceptionally good research infrastructure with a multitude of research services and 
core facilities. These allow scientists to get experienced guidance on a specific technology for a modest 
fee.  Important facilities for MNRP are e.g. Biomedicum Imaging Unit with state-of-the-art confocal 
imaging on fixed and living cells and animals,  transgenic animal unit, the Biomedicum Virus Core for 
retroviral and lentiviral work, Proteomics unit with state-of-the-art mass spectrometry facilities and 
expertise on protein purification and analysis, and deep sequencing methodology on site. For all core 
facilities, see [http://www.biomedicum.fi/index.php?page=251&lang=2]. MNRP has secretarial help, 
technical and IT-support and financial help from the RP-unit core services. 
One of BMH core facilities, the Biomedicum Stem Cell Center (BSCC), is operated within MNRP, by the 
group of TO.  It focuses on human pluripotent stem cells and is able to generate iPS cells from patients’ 
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skin cells. These stem cells can be differentiated into different cell types and used for studying disease 
mechanisms in relevant cells. The BSCC is part of Biocenter Finland-supported National Network since 
2010, and is serving a growing number of investigators. Researchers at MNRP are actively developing 
methods for more efficient production of genetically intact patient-specific iPS. An important report of 
these activities has recently been published (Hussein et al. Nature, on-line publication 3.3.2011).  
All PIs and senior investigators of the RC participate in the teaching of students, either undergraduate or 
graduate.  PIs contribute to medical undergraduate student education on e.g. introductory courses and 
molecular biology (AW), Pediatrics and Endocrinology (TO), Neurology (PT and PL), biochemistry (OE), 
pediatric neurology (TT), and for biology students genetics (IH, AW, BB).  TO is a member of the steering 
committee of the Translational Medicine Master’s program with responsibility of the Regenerative 
Medicine courses, and BB runs the HBGS student weekly research seminars. PT is one of the teachers in 
the “meet the expert” sessions. PT has organized a 30h-annual lecture course entitled “Basic 
Mechanisms of Nervous System Disorders”, which has been designed for the non-medical students of 
the University. In addition, all PIs serve as experts on their topic, giving tens of lectures every year for 
university hospitals, for other universities etc.  The teaching load varies, but in general, all investigators 
in MNRP are able to keep their main emphasis in research. 
 RC’s strengths and challenges related to operational conditions, and the actions planned for their 
development. 
Strengths: 
- Access to state-of-the-art equipment and expertise in a wide selection of core facilities 
- Excellent overall research infrastructure in research program unit and Biomedicum 
- Own active contribution to research infrastructure: Stem Cell Center possesses unique know-how in an 
important new and rapidly developing area of biomedicine.  
- Close contacts to clinics and patients 
 
Challenges: 
- The hospital district does not consider research as important as previously, and the clinician scientists 
are tightly bound to their clinical duties. Research funding of the hospital district (EVO-funds) is 
decreasing in the University hospitals, because more funds are directed into non-academic research 
and development. These aspects are limiting considerably the important contribution of clinicians to 
science. 
 
 
 
 Description of the execution and processes of leadership in the RC, how the management-related 
responsibilities and roles are distributed in the RC and how the leadership- and management-related 
processes support high quality research, collaboration between principal investigators and other 
researchers in the RC, the RC’s research focus and strengthening of the RC’s know-how.  
MNRP is one of the six research programs (RP) at Faculty of Medicine, selected after a competitive 
international evaluation for the term 2007-2012. The whole RP-unit is led by Prof Olli Jänne, and 
representatives of all the RPs form the RP-unit board. This board decides of whole-unit strategies, and 
its representatives inform the individual RPs of the decisions. 
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MNRP director is Anu Wartiovaara, who was nominated at the selection of our RP. The vice director is 
Pentti Tienari.  The director is responsible for the overall management of the unit, including use of space 
and common budgetary funding (unit funds only available in 2010), reporting and RP-applications.  All 
the eight PIs of MNRP are independent concerning their research questions and project funding. 
However, the PIs meet regularly, and decisions on general action plans, investments, leadership,  
student education, and science days are done typically by consensus.  PIs participate in HU boards (e.g. 
Faculty Council, Board of Animal Centre, Biocentrum-Helsinki Board, PhD student board, graduate 
school boards, administrative HU boards). Information from these various instances is spread in PI-
meetings.  
 
The leadership- and management-related process supports high quality research by organizing research 
infrastructure to maximize exchange of information and scientist interaction. An important factor 
promoting exchange of information is our location in a common, continuous space. Offices and 
laboratory space, with their equipment are shared. MNRP has during 2005-10 organized different 
formats of weekly, bi-weekly or monthly research seminars. Currently we have a bi-weekly journal club 
of recent highest profile publications, and start now monthly ‘hot topic’ brain storms, organized by all 8 
research groups on their turn. Furthermore, MNRP organizes yearly ‘Neuro-days’, an overnight science 
retreat, with presentations of MNRP postdocs and students and lively feedback discussions. 
 
MNRP harbors valuable research materials, including hundreds of neurological patient cell lines, tissue 
collections and in-detail characterized autopsy materials from hundreds of subjects. These materials are 
shared between the MNRP groups, when needed, which forms a great resource for all. The newest 
development is utilization of the patient fibroblast and myoblast lines to generate induced pluripotent 
stem cells, and to differentiate them to disease-relevant cell types.    
 
An MNRP group commits to active participation in program activities and contribution in developing the 
collaborative concept. However, research topics evolve based on results, and management aims only to 
foster excellent science, not to restrict individual research groups in their science questions. All our 
research funding is competitive and therefore every PI’s success depends on competitive research 
questions. 
 
RC’s know-how is building up through international and national active science collaboration, active 
visits out and to the unit, as well as recruitment of high-quality scientists. The unit is well established 
and competitive in recruitment. Upon new PI recruitment, a proposal is made to the RP-board by the 
director, but otherwise the groups are independent on their recruitment of scientists. 
 RC’s strengths and challenges related to leadership and management, and the actions planned for 
developing the processes. 
MNRP strengths: 
- strong collaboration emphasis & networking 
- interaction of researchers on daily basis 
- support of exchange of information by common regular seminars and science days 
- common research space and facilities, including shared equipment 
- centrally applied licenses (radioactive work, virus-work)  
- well-working consensus-based decision making  
- active contribution of the unit to develop research environment in the RP-unit and at the university. 
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A true challenge during 2009-10 is the exponentially increased administrative load. During 2009-2010, 
the central HU administration has applied several top-down administrative exercises, which use a lot of 
time of research staff. These include e.g. time-projecting to funding sources, in an hour-by-hour basis. 
As MNRP research is based on funding from tens of different sources, dividing working hours to single 
projects is irrelevant and uninformative.  MNRP is acting through constructive feedback towards HU 
administration to develop bureaucracy to realistic direction and to make the administrative load 
bearable. 
 
 
 
 Listing of the RCs external competitive funding, where: 
- the funding decisions have been made during 1.1.2005-31.12.2010, and 
- the administrator of the funding is/has been the University of Helsinki 
 
 Academy of Finland (AF) - total amount of funding (in euros) AF has decided to allocate to the RC 
members during 1.1.2005-31.12.2010: 4385926 
 
 Finnish Funding Agency for Technology and Innovation (TEKES) - total amount of funding (in euros) 
TEKES has decided to allocate to the RC members during 1.1.2005-31.12.2010: 115000 
 
 European Union (EU) - total amount of funding (in euros) EU has decided to allocate to the RC members 
during 1.1.2005-31.12.2010: 873600 
 
 European Research Council (ERC) - total amount of funding (in euros) ERC has decided to allocate to the 
RC members during 1.1.2005-31.12.2010:  
 
 International and national foundations – names of international and national foundations which have 
decided to allocate funding to the RC members during 1.1.2005-31.12.2010, and the amount of their 
funding (in euros).  
- names of the foundations: Genetics Society of America 
- Sigrid Juselius Foundation 
- Yrjö Jahnsson Foundation 
- Jalmari and Rauha Ahokas Foundation 
- Nylands Nation 
- Research Foundation of Psychiatry (Finnish) 
- Foundation for alcohol research (Finnish) 
- Signe and Ane Gyllenbergs Foundation 
- Jane and Aatos Erkko foundation 
- CIMO 
- Juliana von Wendt Foundation 
- United Mitochondrial Disease Foundation 
- Juvenile Diabetes Research Foundation 
- European Foundation for the Study of Diabetes  
- Diabetes research foundation (Finnish) 
- total amount of funding (in euros) from the above-mentioned foundations: 5483200 
 
7 EXTERNAL COMPETITIVE FUNDING OF THE RC 
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 Other international funding - names of other international funding organizations which have decided to 
allocate funding to the RC members during 1.1.2005-31.12.2010, and the amount of their funding (in 
euros). 
- names of the funding organizations:  
- total amount of funding (in euros) from the above-mentioned funding organizations:  
 
 Other national funding (incl. EVO funding and Ministry of Education and Culture funded doctoral 
programme positions) - names of other national funding organizations which have decided to allocate 
funding to the RC members during 1.1.2005-31.12.2010, and the amount of their funding (in euros). 
- names of the funding organizations: Biocentrum Helsinki 
- Ministry of Education and Culture funded doctoral programme positions 
- University of Helsinki Funds 
- Institute of Molecular Medicine Finland 
- Oy H. Lundbeck Ab 
- Biocenter Finland 
- SPR 
- Orion 
- EVO funding 
- total amount of funding (in euros) from the above-mentioned funding organizations: 4843768 
 
 
 
 Description of the RC’s future perspectives in respect to research and doctoral training. 
The current MNRP term as a research program ends in 2012, but an application for continuation for the 
years 2013-2016 will be submitted. We are well positioned in the application round, as research has 
been flourishing, and expect a continued status. At the application round, we will consider both 
recruitment and exit of groups based on optimal complementary research focus and skills, to compile a 
competitive unit. However, the core of the future unit is based on current structure, and focus is in 
neurological disease and metabolism. 
 
The research focus of future MNRP will continue to be disease oriented and emphasize bridging of 
clinical and basic research. In practice this is realized by involving both practicing clinicians and basic 
scientists as group leaders. MD-PIs are needed to involve medical students in research, an increasing 
challenge because a science career is not viewed as secure or attractive to them anymore. Furthermore, 
the career development of PhD-group leaders in Faculty of Medicine requires attention, as several 
competitive young group leaders need new  positions after their 5-year Academy of Finland scientist 
position expire, and retainment mechanisms or policy are still non-existent in our Faculty.  
 
MNRP’s research continues to be driven by questions arising from our research, and not directed by 
management or commercial interests. However, we do consider patenting, if results are directly 
applicable to diagnosis or treatment. As useful unique disease models in cultured cells and in mice have 
been created, and are being developed at MNRP, their utilization to therapy trials as well as 
understanding mechanisms and physiological consequences of disease is emphasized. Collection and 
analysis of clinical data of our patients, as well as human tissue and cell materials is continued, and 
allows analysis of relevance of in vitro and animal data in human patients. We are in the forefront to 
utilize state-of-the-art genomics for DNA-diagnosis, with our extensive well-characterized patient 
materials,  in-house facilities of deep sequencing and exome-analysis and associated development of 
8 RC’S STRATEGIC ACTION PLAN FOR 2011–2013 (MAX. 4400 CHARACTERS WITH SPACES) 
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bioinformatic pipelines. We will utilize these whole-genome approaches, supported by dense SNP-maps, 
for neurological disease diagnosis. We expect to identify the molecular basis for several new disorders 
of Finnish disease heritage through individual genome analysis.  
 
We will continue our active participation and student enrollment in local active graduate schools, and 
will participate in development of their competitive education curricula, for example by organizing 
courses involving our special expertise.  We will support Faculty’s new direction to establish tenure-
track positions for excellent young group leaders, and support independence of our own senior 
postdocs in their attempts of founding their own research groups.  We aim for students to complete 
their PhD thesis within an average of 4-5 years fulltime research, and MSc thesis within 6 months.  
 
We continue our active collaborations, which are driven by science questions. Our wide networking 
ensures that required new expertise can be obtained from national or international visits.  
 
We continue our active high-quality publication policy, and aim in publishing complete entities, instead 
of splitting data to minor reports. We support Faculty’s new direction of considering the quality of 
publications and extent of PhD training instead of just counting the number of publications. 
 
 
 
All eight research group leaders of MNRP have written and revised the submitted document, as 
representatives of their groups and group members, and the final format was done by the MNRP 
director Anu Wartiovaara. All the RC members have provided their publication and activity data to 
TUHAT database. 
9 SHORT DESCRIPTION OF HOW THE RC MEMBERS HAVE CONTRIBUTED TO THE COMPILATION OF THE STAGE 2 
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1 Analysis of publications 
 
- Associated person is one of Anu Suomalainen Wartiovaara ,  Perttu Lindsberg ,  Timo Pyry Juhani Otonkoski , 
 Brendan Battersby , Pentti Tienari , Iiris Hovatta , Ove 
Eriksson-Rosenberg ,  Tiina Tyni ,  Päivi Miettinen ,  ,  Timo Tuuri , 
Petri Hyytiä ,  Uwe Richter ,  Juuso Johannes Juhila ,  Samer Hussein, 
Karolina Lundin (Stenroos) ,  Ras Trokovic ,  Krista Nuotio ,  ,  
Daniel Strbian ,  Johanna Eerola-Rautio ,  Alessandro Bonetti ,  Christopher John 
Carroll ,  Liliya Euro , Anna Henriikka Hakonen ,  Riikka Hämäläinen , 
 Pirjo Isohanni ,  Petri Luoma ,  Henna Tyynismaa , 
Shuichi Yatsuga ,  Sanna Marjavaara ,  Kati Ahlqvist ,  Sofia Tuulikki Ahola-Erkkilä , 
 Jana Buzkova ,  Alexandra Götz ,  Joni Petteri Nikkanen ,  
Emil Ylikallio ,  Padmini P Polinati ,  Hannu Laaksovirta ,  Terhi Peuralinna , 
 Veli-Matti Isoviita ,  Milla Mikkola (Aho) ,  Elina Hakonen ,  
Sanna Charlotta Toivonen ,  Sanna Maria Vuoristo ,  Pia Isoviita ,  Olli-Pekka Mattila , 
 Jani Saksi ,  ,  Jonas Donner ,  Leena Helena Kilpinen , 
 Tessa Sipilä ,  Annunziata Sonia Cascone ,  Riikka Jokinen ,  
Heidi Junnila ,  
 
Publication year 
Publication type 2005 2006 2007 2008 2009 2010 
Total Count 2005 - 
2010 
A1 Refereed journal article 48 41 31 39 32 40 231 
A2 Review in scientific journal    1 4 6 11 
A3 Contribution to book/other compilations (refereed) 17 18 1 19 2  57 
A4 Article in conference publication (refereed) 2 1 1 1 1 1 7 
B1 Unrefereed journal article 8 2 7 10 3 2 32 
B2 Contribution to book/other compilations (non-refereed) 3 2 1   1 7 
B3 Unrefereed article in conference proceedings 1  1  1  3 
C1 Published scientific monograph   1    1 
D1 Article in professional journal      7 7 
D2 Article in professional hand or guide book or in a professional data 
system, or text book material 
 1   2 1 4 
E1 Popular article, newspaper article 3   3 3 1 10 
H1 Patents     1  1 
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2 Listing of publications 
A1 Refereed journal article 
2005 
Anttonen, A, Mahjneh, I, Hämäläinen, R, Lagier-Tourenne, C, Kopra, O, Waris, L, Anttonen, M, Joensuu, T, Kalimo, H, Paetau, A, 
Tranebjaerg, L, Chaigne, D, Koenig, M, Eeg-Olofsson, O, Udd, B, Somer, M, Somer, H, Lehesjoki, A 2005, 'The gene disrupted in 
Marinesco-Sjögren syndrome encodes SIL1, an HSPA5 cochaperone', Nature Genetics, vol 37, pp. 1309-1311. 
Autti-Rämö, I, Mäkelä, M, Sintonen, H, Koskinen, H, Laajalahti, L, Halila, R, Kääriäinen, H, Lapatto, R, Näntö-Salonen, K, Pulkki, K, 
Renlund, M, Salo, M, Tyni, T 2005, 'Expanding screening for rare metabolic disease in the newborn: An analysis of costs, effect and 
ethical consequences for decision-making in Finland', Acta Paediatrica, vol 94, no. 8, pp. 1126-1136. 
Buervenich, S, Carmine, A, Galter, D, Shahabi, HN, Johnels, B, Holmberg, B, Ahlberg, J, Nissbrandt, H, Eerola-Rautio, J, Hellström, O, 
Tienari, PJ, Matsuura, T, Ashizawa, T 2005, 'A rare truncating mutation in ADH1C (G78Stop) shows significant association with 
Parkinson disease in a large international sample', Archives of Neurology, vol 62, pp. 74-78. 
Buervenich, S, Carmine, A, Galter, D, Shahabi, HN, Johnels, B, Holmberg, B, Ahlberg, J, Nissbrandt, H, Eerola, J, Hellstrom, O, Tienari, 
P, Matsuura, T, Ashizawa, T, Wullner, U, Klockgether, T, Zimprich, A, Gasser, T, Hanson, M, Waseem, S, Singleton, A, McMahon, FJ, 
Anvret, M, Sydow, O, Olson, L 2005, 'A rare truncating mutation in ADH1C (G 78Stop) shows significant association with Parkinson 
disease in a large international sample', Archives of Neurology, vol 62, pp. 74-78. 
Clarimon, J, Xiromerisiou, G, Eerola-Rautio, J, Gourbali, V, Hellström, O, Dardiotis, E, Peuralinna, T, Papadimitriou, A, Hadjigeorgiou, 
GM, Tienari, PJ, Singleton, AB 2005, 'Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish 
and Greek patients', BMC Neurology, no. Jun 20, 5 s. 
Eerola, J, Tienari, PJ, Kaakkola, S, Nikkinen, P, Launes, J 2005, 'How useful is [123I]beta-CIT SPECT in clinical practice?', Journal of 
Neurology, Neurosurgery and Psychiatry, vol 76, no. 9, pp. 1211-1216. 
Gao, R, Ustinov, JA, Korsgren, O, Otonkoski, T 2005, 'In vitro neogenesis of human islets reflects the plasticity of differentiated human 
pancreatic cells', Diabetologia, vol 48, pp. 2296-2304. 
Geutskens, SB, Otonkoski, T, Pulkkinen, M, Drexhage, HA, Leenen, PJM 2005, 'Macrophages in the murine pancreas and their 
involvement in fetal endocrine development in vitro', Journal of Leukocyte Biology, vol 78, pp. 845-852. 
Greggio, E, Bergantino, E, Carter, D, Ahmad, R, Costin, G, Hearing, VJ, Clarimon, J, Singleton, A, Eerola-Rautio, J, Hellström, O, 
Tienari, PJ, Miller, DW, Beilina, A, Bubacco, L, Cookson, MR 2005, 'Tyrosinase exacerbates dopamine toxicity but is not genetically 
associated with Parkinson's disease', Journal of Neurochemistry, vol 93, pp. 246-256. 
Hakonen, AH, Juvonen, V, Paetau, I, Luoma, P, Rantamäki, M, Goethem, G, Löfgren, A, Hackman, P, Paetau, A, Kaakkola, S, 
Majamaa, K, Varilo, T, Udd, B, Kääriäinen, H, Bindoff, LA, Suomalainen Wartiovaara, A 2005, 'Uusi yleinen suomalainen periytyvä 
ataksia', Duodecim, vol 121, no. 24, pp. 2637. 
Hakonen, AH, Heiskanen, S, Juvonen, V, Paetau, I, Luoma, P, Rantamäki, M, Van Goethem, G, Löfgren, A, Hackman, P, Paetau, A, 
Kaakkola, S, Majamaa, K, Varilo, T, Udd, B, Kääriäinen, H, Bindoff, LA, Suomalainen, AE 2005, 'Mitochondrial DNA polymerase W748S 
mutation: a common cause of autosomal recessive ataxia with ancient European origin', American Journal of Human Genetics, vol 
77, no. 3, pp. 430-441. 
Hermann, R, Mantere, J, Lipponen, K, Veijola, R, Soltesz, G, Otonkoski, T, Simell, O, Knip, M, Ilonen, J 2005, 'Lack of Association of 
PAX4 Gene With Type 1 Diabetes in the Finnish and Hungarian Populations',  Diabetes, vol 54, pp. 2816-2819. 
Hienonen, T, Sammalkorpi, H, Isohanni, P, Versteeg, R, Karikoski, R, Aaltonen, LA 2005, 'A 17p11.2 germline deletion in a patient with 
Smith-Magenis syndrome and neuroblastoma', Journal of Medical Genetics, vol 42, no. 1, pp. e3. 
Holopainen, JM, Soderlund, T, Alakoskela, JM, Sailya, M, Eriksson, O, Kinnunen, PKJ 2005, 'Intermolecular interactions of 
lysobisphosphatidic acid with phosphatidylcholine in mixed bilayers', Chemistry and Physics of Lipids, vol 133, no. 1, pp. 51-67. 
Hovatta, I, Tennant, RS, Helton, R, Marr, RA, Singer, O, Redwine, JM, Ellison, JA, Schadt, EE, Verma, IM, Lockhart, DJ, Barlow, C 
2005, 'Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice', Nature Medicine, vol 438, pp. 662-666. 
Jauhiainen, M, Setala, NL, Ehnholm, C, Metso, J, Tervo, TMT, Eriksson, O, Holopainen, JM  2005, 'Phospholipid transfer protein is 
present in human tear fluid', Biochemistry, vol 44, no. 22, pp. 8111-8116. 
Johans, M, Milanesi, E, Franck, M, Johans, C, Liobikas, J, Panagiotaki, M, Greci, L, Principato, G, Kinnunen, P, Bernardi, P, Costantini, 
P, Eriksson, O 2005, 'Modification of permeability transition pore arginine(s) by phenylglyoxal derivatives in isolated mitochondria and 
mammalian cells: Structure-function relationship of arginine ligands', Journal of Biological Chemistry, vol 280, no. 13, pp. 12130-
12136. 
Juhila, J, Honkanen, A, Sallinen, J, Haapalinna, A, Korpi, ER, Scheinin, M 2005, 'alpha(2A)-Adrenoceptors regulate D-amphetamine-
induced hyperactivity and behavioural sensitization in mice', European Journal of Pharmacology, vol 517, pp. 74-83. 
Jukkola, T, Trokovic, R, Maj, P, Lamberg, A, Mankoo, B, Pachnis, V, Savilahti, H, Partanen, J 2005, 'Meox1[sup Cre]: a mouse line 
expressing Cre recombinase in somitic mesoderm', Genesis: The Journal of Genetics and Development , vol 43, no. 3, pp. 148-153. 
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Kallijärvi, J, Lahtinen, U, Hämäläinen, R, Lipsanen-Nyman, M, Palvimo, J, Lehesjoki, A 2005, 'TRIM37 defective in mulibrey nanism is a 
novel RING finger ubiquitin E3 ligase', Experimental Cell Research, vol 308, no. 1, pp. 146-155. 
Laaksovirta, H 2005, 'ALS-potilaan oireenmukainen hoito vaatii osaamista', Duodecim, vol 121, pp. 220-224. 
Lehtonen-Smeds, EMP, Mäyränpää, M, Soinne, L, Saimanen, E, Järvinen, A, Salonen, O, Carpen, O, Lassila, R, Sarna, S, Kaste, M, 
Kovanen, PT, Lindsberg, P 2005, 'Carotid plaque mast cells associate with atherogenic serum lipids, high grade carotid stenosis and 
symptomatic carotid artery disease: Results from the Helsinki carotid endarterectomy study',  Cerebrovascular Diseases, vol 19, no. 5, 
pp. 291-301. 
Lincoln, MR, Montpetit, A, Cader, ZM, Saarela, J, Dyment, DA, Tiislar, M, Ferretti, V, Tienari, PJ, Sadovnik, AD, Peltonen, L, Ebers, GC, 
Hudson, TJ 2005, 'A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis: [letters]',  
Nature Genetics, vol 37, no. 10, pp. 1108-1112. 
Lindsberg, PJ, Soinne, L, Roine, RO, Tatlisumak, T 2005, 'Options for recanalization therapy in basilar artery occlusion', Stroke, vol 36, 
pp. 203-204. 
Lindsberg, PJ 2005, 'Basiliaaritromboosi: diagnostinen ja hoidollinen haaste', Suomen lääkärilehti , vol 60, no. 45, pp. 4623-4627. 
Lozada, A, Munyao, N, Sallmen, T, Lintunen, M, Leurs, R, Lindsberg, PJ, Panula, P 2005, 'Postischemic regulation of central histamine 
receptors', Neuroscience, vol 136, no. 1, pp. 371-379. 
Luoma, P, Luo, N, Löscher, WN, Farr, CL, Horvath, R, Wanschitz, J, Kiechl, S, Kaguni, LS, Suomalainen, AE 2005, 'Functional defects 
due to spacer-region mutations of human mitochondrial DNA polymerase in a family with an ataxia-myopathy syndrome', Human 
Molecular Genetics, vol 14, pp. 1907-1920. 
Meissner, T, Friedmann, B, Okun, JG, Schwab, MA, Otonkoski, T, Bauer, T, Bärtsch, P, Mayatepek, E  2005, 'Massive insulin secretion 
in response to anaerobic exercise in exercise-induced hyperinsulinism', Hormone and Metabolic Research, vol 37, pp. 690-694. 
Melberg, A, Nennesmo, I, Moslemi, A, Kolberg, G, Luoma, P, Suomalainen, AE, Holme, E, Oldfors, A 2005, 'Alzheimer pathology 
associated with POLG1 mutation, multiple mtDNA deletions, and APOE4/4: premature ageing or just coincidence?', Acta 
Neuropathologica, vol 110, pp. 315-316. 
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Nikali, K, Suomalainen, AE, Saharinen, J, Kuokkanen, M, Spelbrink, JN, Lönnqvist, T, Peltonen, L 2005, 'Infantile onset spinocerebellar 
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Lindsberg, PJ, Kallela, M 2006, 'Status epilepticuksen diagnostiikka', Tehohoito-opas, Duodecim, Helsinki, pp. 159-161. 
Lindsberg, P, Kaakkola, S 2006, 'Neurologia', in V Pettilä, M Renko, P Kurtti (eds), Terapia-Muistio , 2 edn, Orion, pp. 97-116. 
Ruutiainen, J, Tienari, PJ 2006, 'MS-tauti ja muut demyelinaatiosairaudet', Neurologia, Duodecim, Helsinki, pp. 379-394. 
Ruutiainen, J, Tienari, P 2006, 'Multippeliskleroosi ja muut demyelinaatiotaudit', Neurologia, Duodecim, Helsinki, pp. 379-394. 
Somer, H, Tienari, PJ 2006, 'Neurogenetiikka', Neurologia, Duodecim, Helsinki, pp. 534-551. 
Tienari, PJ, Polvikoski, T 2006, 'Alzheimerin taudin patogeneesi', Muistihäiriöt ja dementia, Duodecim, Helsinki, pp. 108-123. 
Tienari, P 2006, 'MS-taudin epidemiologia ja genetiikka', Kliininen neuroimmunologia, Yliopistopaino, Helsinki, pp. 98-102. 
Wartiovaara, A, Peltola Mjosund, KE, Paetau, A, Wallgren-Pettersson, C 2006, 'Experimental models of muscle diseases', Handbook 
of experimental neurology, Cambridge University Press, Cambridge, pp. 544-561. 
2007 
Laaksovirta, H 2007, 'Amyotrofinen lateraaliskleroosi', Therapia Fennica, Kandidaattikustannus Lääketieteen kandidaattiseura, 
[Helsinki], pp. 607-608. 
2008 
Kallela, M, Lindsberg, PJ 2008, 'Tajuton potilas', Lääkärin käsikirja, Duodecim, Helsinki, pp. 1273-1275. 
Laaksovirta, H 2008, 'Amyotrofinen lateraaliskleroosi (ALS)', Lääkärin käsikirja, Duodecim, Helsinki, pp. 1335-1337. 
Lindsberg, PJ, Kotila, M, Varpula, T 2008, 'Kouristelun diagnostiikka', Akuuttihoito-opas / toimittajat. Erkki Elonen, Markku 
Mäkijärvi, Matti Vuoristo., Duodecim, Helsinki, pp. 315-318. 
Lindsberg, PJ, Kaste, M 2008, 'Tajuttoman potilaan statuslöydökset', Akuuttihoito-opas / toimittajat. Erkki Elonen, Markku Mäkijärvi, 
Matti Vuoristo., Duodecim, Helsinki, pp. 310-313. 
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Lindsberg, PJ, Kotila, M, Varpula, T 2008, 'Status epilepticus', Akuuttihoito-opas / toimittajat. Erkki Elonen, Markku Mäkijärvi, Matti 
Vuoristo., Duodecim, Helsinki, pp. 319-320. 
Lindsberg, PJ, Kaste, M 2008, 'Medullakompression hoito', Akuuttihoito-opas / toimittajat. Erkki Elonen, Markku Mäkijärvi, Matti 
Vuoristo., Duodecim, Helsinki, pp. 336-337. 
Lindsberg, PJ, Kotila, M, Varpula, T 2008, 'Kouristelun hoitoperiaatteet', Akuuttihoito-opas / toimittajat. Erkki Elonen, Markku 
Mäkijärvi, Matti Vuoristo., Duodecim, Helsinki, pp. 318-319. 
Lindsberg, PJ, Kotila, M, Varpula, T 2008, 'Yleisanestesia status epilepticuksen hoidossa', Akuuttihoito-opas / toimittajat. Erkki 
Elonen, Markku Mäkijärvi, Matti Vuoristo., Duodecim, Helsinki, pp. 320-323. 
Lindsberg, PJ, Kaste, M 2008, 'Tajuttoman potilaan ensiarvio', Akuuttihoito-opas, Duodecim, Helsinki, pp. 307-308. 
Lindsberg, PJ, kaste, M 2008, 'Tajuttoman potilaan tutkimukset', Akuuttihoito-opas / toimittajat. Erkki Elonen, Markku Mäkijärvi, 
Matti Vuoristo., Duodecim, Helsinki, pp. 313-315. 
Lindsberg, PJ, Kaste, M 2008, 'Medullakompression diagnostiikka ja tutkiminen',  Akuuttihoito-opas / toimittajat. Erkki Elonen, 
Markku Mäkijärvi, Matti Vuoristo., Duodecim, Helsinki, pp. 333-336. 
Lindsberg, PJ, Kaste, M 2008, 'Tajuttomuuden syyt', Akuuttihoito-opas / toimittajat. Erkki Elonen, Markku Mäkijärvi, Matti 
Vuoristo., Duodecim, Helsinki, pp. 309-310. 
Roine, RO, Lindsberg, PJ, Kaste, M 2008, 'Basilaarivaltimon tukos', Akuuttihoito-opas / toimittajat. Erkki Elonen, Markku Mäkijärvi, 
Matti Vuoristo., Duodecim, Helsinki, pp. 354-355. 
Roine, RO, Lindsberg, PJ, Kaste, M 2008, 'Kaulavaltimon dissektoituma', Akuuttihoito-opas / toimittajat. Erkki Elonen, Markku 
Mäkijärvi, Matti Vuoristo., Duodecim, Helsinki, pp. 354. 
Roine, RO, Lindsberg, PJ, Kaste, M 2008, 'Sinustromboosi', Akuuttihoito-opas / toimittajat. Erkki Elonen, Markku Mäkijärvi, Matti 
Vuoristo., Duodecim, Helsinki, pp. 355-356. 
Roine, RO, Lindsberg, PJ, Kaste, M 2008, 'Aivoinfarktin ensihoito ja diagnostiikka', Akuuttihoito-opas / toimittajat. Erkki Elonen, 
Markku Mäkijärvi, Matti Vuoristo., Duodecim, Helsinki, pp. 347-350. 
Roine, RO, Lindsberg, PJ, Kaste, M 2008, 'Aivovaltimotukoksen liuotushoito', Akuuttihoito-opas / toimittajat. Erkki Elonen, Markku 
Mäkijärvi, Matti Vuoristo., Duodecim, Helsinki, pp. 352-353. 
Roine, RO, Lindsberg, PJ, Kaste, M 2008, 'Antikoagulanttihoito aivovaltimotukoksessa', Akuuttihoito-opas / toimittajat. Erkki Elonen, 
Markku Mäkijärvi, Matti Vuoristo., Duodecim, Helsinki, pp. 353-354. 
Roine, RO, Lindsberg, PJ, Kaste, M 2008, 'Aivoinfarktin hoito', Akuuttihoito-opas / toimittajat. Erkki Elonen, Markku Mäkijärvi, Matti 
Vuoristo., Duodecim, Helsinki, pp. 350-352. 
2009 
Hovatta, I 2009, 'Genetic influence on CNS gene expression: impact on behavior', in ELRS (ed.), Encyclopedia of neuroscience, 
Elsevier Academic Press,, Amsterdam, pp. 647-654. 
Zapala, M, Barlow, C, Hovatta, I 2009, 'Molecular anatomy of the mammalian brain', Encyclopedia of Neuroscience. volume 4., 
Oxford: Academic Press, pp. 913-919. 
A4 Article in conference publication (refereed) 
2005 
Immonen, IJ, Eerola, J, Tienari, PJ, Tervo, T, Moilanen, J, Ranta, P, Tommila, P, Holopainen, J 2005, ApoE e3 haplotype modulating 
the risk of Alzheimer's disease does not affect the risk of age-related macular degeneration,, Investigative Ophthalmology & Visual 
Science 46 Association for Research in Vision and Ophthalmology, etc.. 
Otonkoski, T, Ustinov, J, Hakonen, E, Tammivuori, P, Gao, R, Palgi, J, Miettinen, PJ 2005, Downregulation of EGF receptor in the islets 
causes diabetes due to defects in beta-cell growth and function,, Diabetes 54 American Diabetes Association. 
2006 
Gao, R, Ustinov, J, Korsgren, O, Otonkoski, T  2006, Effects of immunosuppressive drugs on human islet neogenesis in vitro,, 
Diabetologia 49 SPRINGER. 
2007 
Leppäranta, M, Shirasawa, K, Uusikivi, J, Wang, K, Mattila, O, Kangas, A 2007, 'Sea Ice Station Umeå, Winter 2005', in Fifth 
workshop on Baltic sea ice climate, pp. 29-36. 
2008 
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Inoue, T, Ide, T, Tyynismaa, H, Yoshida, M, Ando, M, Tanaka, A, Todaka, K, Kang, D, Suomalainen, A, Sunagawa, K 2008, 
Overexpression of Mitochondria DNA Helicase, Twinkle, Ameliorates Cardiac Remodeling and Failure in Mice,, Circulation Research 
118 LIPPINCOTT WILLIAMS & WILKINS. 
2009 
Guse, K, Tyynismaa, H, Ahola-Erkkilä, ST, Suomalainen, A, Pesonen, S, Cerullo, V, Hemminki, A 2009, Capsid Modified Adenoviruses 
Display Robust, Long Term Gene Expression in Adult Skeletal Muscle Tissue\, , Molecular therapy 17 ACADEMIC PRESS.. 
2010 
Mervaala, E, Biala, A, Merasto, S, Lempiainen, J, Mattila, I, Martonen, EE, Eriksson, O, Louhelainen, M, Finckenberg, P, Kaheinen, P, 
Muller, DN, Luft, FC, Lapatto, R, Oresic, M 2010, Metabolomics in Angiotensin II-Induced Cardiac Hypertrophy,, Paper presented at 
63rd Annual Fall Conference and Scientific Sessions of the American-Heart-Association-Council-for-High-Blood-Pressure-
Research, Chicago, IL, SEP 23-26, 2009. Hypertension 55 2 LIPPINCOTT WILLIAMS & WILKINS. 
B1 Unrefereed journal article 
2005 
Hennah, W, Tuulio-Henriksson, A, Paunio, T, Ekelund, J, Kilpinen, H, Palo, OM, Silander, K, Partonen, T, Lönnqvist, J, Peltonen, L 
2005, 'Two biologically interacting genes, DISC1 and NDE1, associate with schizophrenia and visual working memory functions: 
[Abstract, XIII World Congress on Psychiatric Genetics 2005]', American journal of medical genetics. Part B, Neuropsychiatric 
genetics, vol 138B, no. 1, pp. 123-123. 
Huopio, H, Laakso, M, Otonkoski, T 2005, 'Synnynnäinen hyperinsulinismi: [katsaus]', Duodecim, vol 121, pp. 1166-1175. 
Lindsberg, PJ 2005, 'High blood pressure after acute cerebrovascular occlusion: risk or risk marker? : [editorial comment]',  Stroke, vol 
36, no. 2, pp. 268-269. 
Lindsberg, PJ 2005, 'Riittääkö likvorin silmämääräinen tarkastus subaraknoidaalivuodon diagnostiikkaan?: [pääkirjoitus]',  Duodecim, vol 
121, no. 14, pp. 1489-1492. 
Lindsberg, PJ 2005, 'What Causes the Acute Blood Pressure Elevation After Stroke?: [response]', Stroke, vol 36, no. 10, pp. 2066. 
Lindsberg, PJ 2005, 'Äkillinen uneliaisuus: [vinkistä vihiä]', Duodecim, vol 121, no. 10, pp. 1101, 1103. 
Wartiovaara, A 2005, 'Vastine edelliseen: [kirjeitä ja mielipiteitä]', Duodecim, vol 121, pp. 2008-2009. 
Wartiovaara, A 2005, 'Zen ja mitokondrioiden kunnossapito: [pääkirjoitus]', Duodecim, vol 121, pp. 1265-1267. 
2006 
Lindsberg, PJ, Mattle, HP 2006, 'Response to Letter by Ciccone et al', Stroke, vol 37, pp. 1963-1964. 
Lindsberg, PJ, Mattle, HP 2006, 'Response to letter by Schonewille et al', Stroke, vol 37, pp. 2207. 
2007 
Hovatta, I 2007, 'Ahdistuneisuuden genetiikka: spesifisten geenien tunnistus on alkanut : [pääkirjoitus]',  Duodecim, vol 123, no. 14, pp. 
1665-1666. 
Ijäs, P, Nuotio, K, Saksi, J, Soinne, L, Saimanen, E, Karjalainen-Lindsberg, M, Salonen, O, Sarna, S, Tuimala, J, Kovanen, PT, Kaste, 
M, Lindsberg, PJ 2007, 'Mikroverenvuodot ja CD163-HO1-signalointi oireilevassa kaukavaltimon ateroskleroosissa: [Arterioscler Thromb 
Vasc Biol in press]', Duodecim, vol 123, pp. 141-142. 
Laaksovirta, H 2007, 'Perheittäin esiintyvä ja periytyvä amyotrofinen lateraaliskleroosi (FALS ja SOD1-ALS): [katsausartikkeli]',  
Duodecim, vol 62, no. 26, pp. 2555-2558. 
Lindsberg, PJ, Mattle, HP 2007, 'Response to letter by Vatankhah et al', Stroke, vol 38, pp. e30. 
Lindsberg, PJ 2007, 'Response to letter by Schulte-Altedorneburg et al', Stroke, vol 38, pp. 10-11. 
Strbian, D, Karjalainen-Lindsberg, M, Kovanen, PT, Tatlisumak, T, Lindsberg, PJ 2007, 'Syöttösolujen stabilointi vähentää liuotushoidon 
aiheuttamaa verenvuotoa ja kuolleisuutta kokeellisessa aivoinfarktissa: [in press Circulation]', Duodecim, vol 123, pp. 1808-1809. 
Tienari, PJ 2007, 'Uudet geneettiset löydökset', Avain : neurologinen aikakauslehti, vol 37, no. 5, pp. 26-27. 
2008 
Billestrup, N, Otonkoski, T 2008, 'Dedifferentiation for replication of human beta-cells: a division between mice and men?', Diabetes, vol 
57, pp. 1575-1583. 
Bogolovsky, T, Häppölä, O, Tatlisumak, T, Kaste, M, Lappalainen, K, Paananen, T, Lindsberg, PJ 2008, 'Edellisen johdosta: letter', 
Duodecim, vol 124, pp. 1137-1138. 
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Hanley, N, Hanley, K, Miettinen, P, Otonkoski, T 2008, 'Weighing up beta-cell mass in mice and humans: Self-renewal, progenitors or 
stem cells?', Molecular and Cellular Endocrinology, vol 288, pp. 79-85. 
Hovatta, I, Paunio, T 2008, 'Mieli, keho ja geenit', Duodecim, vol 124, no. 6, pp. 675-677. 
Lindsberg, PJ 2008, 'Kun muistijälki ei tartu: Tilapäisen täydellisen muistinmenetyksen taustat : katsaus', Duodecim, vol vol 124, pp. 
781-788. 
Miettinen, P, Ormio, P, Hakonen, E, Banerjee, M, Otonkoski, T  2008, 'EGF receptor in pancreatic beta-cell mass regulation', 
Biochemical Society Transactions, vol 36, pp. 280-285. 
Mohnike, K, Blankenstein, O, Minn, H, Mohnike, W, Fuchtner, F, Otonkoski, T  2008, '[18F]-DOPA positron emission tomography for 
preoperative localization in congenital hyperinsulinism', Hormone Research, vol 70, no. 2, pp. 65-72. 
Silvennoinen, H, Hamberg, L, Lindsberg, PJ, Valanne, L, Hunter, GJ 2008, 'TT-perfuusiokuvaus osoitti liuotushoidon suurentavan 
infarktilta säästynyttä aivokudosaluetta: [ in press AJNR Am J Neuroradiol ]', Duodecim, vol 124, pp. 1203-1204. 
Strandberg, TE, Pitkälä, K, Tienari, PJ, Tilvis, RS 2008, 'Education and dementia: what lies behind the association? : [to the editor]', 
Neurology, vol 71, pp. 1555-1556. 
Virtanen, I, Banerjee, M, Palgi, J, Korsgren, O, Lukinius, A, Thornell, L, Kikkawa, Y, Sekiguchi, K, Hukkanen, M, Konttinen, YT, 
Otonkoski, T 2008, 'Ihmisen haimasaarekkeiden erityislaatuinen tyvikalvorakenne: [referaatti Diabetologia-lehden artikkelista]', 
Duodecim, vol 124, pp. 1205-1206. 
2009 
Lindsberg, PJ, Koistinaho, J, Tienari, PJ 2009, 'Minosykliini - harvinaisen "laajakirjoinen" antibiootti: [pääkirjoitus]', Duodecim, vol 125, 
pp. 123-125. 
Lindsberg, PJ 2009, 'Kädellisten ryhmäkanne Bill Gatesia vastaan: [kolumni]', Duodecim, vol 125, pp. 1306-1307. 
Trokovic, R, Lindholm, DB 2009, 'Inducerade pluripotenta stamceller – nya löften och möjligheter för forskning och terapi', Finska 
Läkaresällskapets Handlingar. 
2010 
Laurent, LC, Nievergelt, CM, Lynch, C, Fakunle, E, Harness, JV, Schmidt, U, Galat, V, Laslett, AL, Otonkoski, T, Keirstead, HS, Schork, 
A, Park, H, Loring, JF 2010, 'Restricted ethnic diversity in human embryonic stem cell lines',  Nature methods., vol 7, no. 1, pp. 6-7. 
Lindsberg, P, Uotila, L 2010, 'Varoitusvuodoista ja likvorin spektritutkimuksesta', Duodecim, vol 126, pp. 1356-1358. 
B2 Contribution to book/other compilations (non-refereed) 
2005 
Hovatta, I, Saarela, J 2005, 'Affymetrix GeneChip system', in J Tuimala, M Laine (eds), DNA Microarray Data Analysis, CSC - 
Scientific Computing Ltd., pp. 25-31. 
Hovatta, I, Barlow, C 2005, 'Genome to Disease', in S Koslow, S Subramaniam (eds), Databasing the Brain. Data to Knowledge., 
John Wiley and Sons, Inc, pp. 169-190. 
Suomalainen Wartiovaara, A, Syvänen, A 2005, 'Affinity-capture and solid-phase sequencing of biotinylated PCR products', in J Morgan 
(ed.), Nucleic acids protocols handbook, Humana Press. 
2006 
Suomalainen Wartiovaara, A, Syvänen, A 2006, 'Analysis of Nucleotide sequence variations by solid-phase minisequencing', in J 
Morgan (ed.), Nucleic acids protocols handbook, Humana Press. 
Suomalainen Wartiovaara, A, Peltola, KE, Paetau, A, Wallgren-Pettersson, C 2006, 'Experimental models of muscle disease', in T 
Tatlisumak, M Fischer (eds), Methods and Techniques in Animal Reserach. Handbook of experimental neurology., Cambridge 
University Press. 
2007 
Suomalainen Wartiovaara, A, Syvänen, A 2007, 'Quantitative analysis of DNA sequences by PCR and solid-phase minisequencing', in 
JM Walker, R Rapley (eds), Medical Biomethods Handbook, Humana Press. 
2010 
Hovatta, I, Sipilä, TLM 2010, 'Molecular genetics of anxiety', Encyclopedia of Life Sciences, John Wiley & Sons, Chichester . 
B3 Unrefereed article in conference proceedings 
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2005 
Leppäranta, M, Mattila, O 2005, 'Supraglasiaalisen Suvivesi-järven elinkaari Antarktikassa', in  Geofysiikan päivät XXII. 
2007 
Mattila, O, Leppäranta, M 2007, 'Lumen ilmastollisen herkkyyden tarkastelu arktisella jäätiköllä Koillismaalla, Huippuvuorilla', in  XXIII 
GEOFYSIIKAN PÄIVÄT, pp. 101-106 Geofysiikan päivät. 
2009 
Isohanni, P, Loennqvist, T, Linnankivi, T, Uusimaa, J, Harju, A, Paetau, A, Kalimo, H, Valanne, L, Suomalainen, A, Pihko, H  2009, 
'POLG MUTATIONS CAUSE SEVERE EARLY ONSET EPILEPSY WITH LIVER FAILURE', in  8th European Congress on 
Epileptology, pp. 117-117. 
C1 Published scientific monograph 
2007 
Kanto, E, Leppäranta, M, Mattila, O 2007, Seasonal snow in Antarctica: data report II, Report series in geophysics / University of 
Helsinki, no. 55, University of Helsinki, Division of Geophysics, Helsinki. 
D1 Article in professional journal 
2010 
Hakonen, AH, Isohanni, P, Rantamäki, M, Kälviäinen, R, Nordin, A, Uusimaa, J, Paetau, A, Udd, B, Pihko, H, Wartiovaara, A  2010, 
'Mitokondriaalinen resessiivinen ataksia-syndrooma ja valproaattihoidon toksisuus', Duodecim, vol 126, no. 13, pp. 1552-1559. 
Hovatta, I, Tienari, P, Sajantila, A, Wartiovaara, A 2010, 'Tutkijoiden kouluttajien haasteet', Duodecim, vol 126, no. 19, pp. 2301-2303. 
Kere, J, Meri, S, Suomalainen Wartiovaara, A 2010, 'Molekyyligenetiikan huima neljännesvuosisata (Two decades of molecular 
genetics)', Duodecim, vol 126, no. 19, pp. 2297-2299. 
Sairanen, T, Rantanen, K, Lindsberg, P 2010, 'TIA:n diagnostiikka ja nykyhoito', Duodecim, vol 126, no. 12, pp. 1401-10. 
Silvennoinen, H, Lindsberg, P, Valanne, L 2010, 'Perfuusiokuvaus aivoiskemian diagnostiikassa',  Duodecim, vol 126, no. 1, pp. 33-39. 
Tienari, P 2010, 'Multippeliskleroosi (MS-tauti)',  Duodecim, vol 126, no. 21, pp. 2525-7. 
Tienari, P 2010, 'Internetissä kiehuu - tutkijat suosittelevat jäitä hattuun', Avain : neurologinen aikakauslehti, vol 2010, no. 3, pp. 5. 
D2 Article in professional hand or guide book or in a professional data system, or text book 
material 
2006 
Kaste, M, Sairanen, T, Häppölä, O, Lassila, R, Lepäntalo, M, Lindsberg, PJ, Lohi, J, Pesonen, H, Pohjasvaara, T, Poutiainen, E, 
Rissanen, A, Roine, RO, Sivenius, J, Strandberg, T, Syvänne, M, Turkka, J, Suomalaisen Lääkäriseuran Duodecimin ja Suomen 
Neurologinen Yhdistys ry:n asettama työryhmä 2006, 'Aivoinfarkti: Käypä hoito -suositus', Aivoinfarkti. Käypä hoito -suositus.. 
2009 
Lindsberg, P, Kallela, KMJ 2009, 'Tajuton potilas: Comatose patient', in I Kunnamo (ed.), Lääkärin käsikirja. Physician's Desk 
Reference Book., Duodecim. 
Lindsberg, P, Kaakkola, S 2009, 'Neurologia', in V Pettilä, M Renko, P Kurtti (eds), Terapia-muistio, Orion, Espoo. 
2010 
Tienari, P, Polvikoski, TM, Tanila, H 2010, 'Alzheimerin taudin patogeneesi', in T Erkinjuntti, J Rinne, H Soininen (eds), 
Muistisairaudet, Duodecim, Porvoo. 
E1 Popular article, newspaper article 
2005 
Mattila, O 2005, 'FINNARP 2004 - kum kotimaan lumi ja jää eivät riitä', Geologi, vol 57, pp. 66-68. 
Otonkoski, TPJ 2005, 'Kantasoluhoidoissa toiveet eivät aina vastaa todellisuutta', Helsingin Sanomat. 
Tienari, P 2005, 'Suuria lupauksia, suuria haasteita: MS ja ihmisperimä.', Avain : neurologinen aikakauslehti, vol 2005, no. 3, pp. 6-8. 
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2008 
Alitalo, K, Otonkoski, TPJ 2008, 'Vieraskynä/Pääkirjoitus: Kantasolukeksintö mahdollistaa henkilökohtaiset soluvaraosat', Helsingin 
Sanomat. 
Otonkoski, TPJ 2008, 'Kantasoluhoidossa toiveet eivät aina vastaa todellisuutta', Helsingin Sanomat. 
Peuralinna T, Oinas M, Polvikoski T, Paetau A, Sulkava R, Niinistö L, Kalimo H, Hernandez D, Hardy J, Singleton A, Tienari PJ, 
Myllykangas L  2008, 'Geenivariantti suojaa aivoja vanhuusiän rappeumamuutoksilta', Duodecim, vol 124, no. 16, pp. 1855. 
2009 
Lindsberg, PJ 2009, 'Tahtomattaan facebookissa: Kuka hyötyy nenänsä pistämisestä nettiin?', Duodecim, vol 2009, 1 s. 
Lindsberg, PJ 2009, 'Terveysvaikutteinen media-ilta', Duodecim, vol 2009, 2s. 
Tienari, PJ 2009, 'Perimä ja MS', Avain : neurologinen aikakauslehti, vol 40, no. 3, pp. 26-30. 
2010 
Laaksovirta, H 2010, 'Kansainvälinen tutkimus toi lisätietoa ALS:in syntymekanismeista', Porras, no. 5. 
H1 Patents 
2009 
Suomalainen Wartiovaara, A, Tyynismaa, H, Raimundo, N 2009, Serum diagnostics for mitochondrial disease, PCT/FI2010/050223. 
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- Associated person is one of Anu Suomalainen Wartiovaara ,  Perttu Lindsberg ,  Timo Pyry Juhani Otonkoski , 
 Brendan Battersby , Pentti Tienari , Iiris Hovatta , Ove 
Eriksson-Rosenberg ,  Tiina Tyni ,  Päivi Miettinen ,  ,  Timo Tuuri , 
Petri Hyytiä ,  Uwe Richter ,  Juuso Johannes Juhila ,  Samer Hussein, 
Karolina Lundin (Stenroos) ,  Ras Trokovic ,  Krista Nuotio ,  ,  
Daniel Strbian ,  Johanna Eerola-Rautio ,  Alessandro Bonetti ,  Christopher John 
Carroll ,  Liliya Euro , Anna Henriikka Hakonen ,  Riikka Hämäläinen , 
 Pirjo Isohanni ,  Petri Luoma ,  Henna Tyynismaa , 
Shuichi Yatsuga ,  Sanna Marjavaara ,  Kati Ahlqvist ,  Sofia Tuulikki Ahola-Erkkilä , 
 Jana Buzkova ,  Alexandra Götz ,  Joni Petteri Nikkanen ,  
Emil Ylikallio ,  Padmini P Polinati ,  Hannu Laaksovirta ,  Terhi Peuralinna , 
 Veli-Matti Isoviita ,  Milla Mikkola (Aho) ,  Elina Hakonen ,  
Sanna Charlotta Toivonen ,  Sanna Maria Vuoristo ,  Pia Isoviita ,  Olli-Pekka Mattila , 
 Jani Saksi ,  ,  Jonas Donner ,  Leena Helena Kilpinen , 
 Tessa Sipilä ,  Annunziata Sonia Cascone ,  Riikka Jokinen ,  
Heidi Junnila ,  
 
Activity type Count 
Supervisor or co-supervisor of doctoral thesis 33 
Prizes and awards 23 
Editor of research journal 8 
Peer review of manuscripts 35 
Editor of communication journal 1 
Assessment of candidates for academic posts 2 
Membership or other role in review committee 2 
Membership or other role in research network 4 
Membership or other role in national/international committee, council, board 45 
Membership or other role in public Finnish or international organization 2 
Participation in interview for written media 14 
Participation in radio programme 10 
Participation in TV programme 5 
Participation in interview for web based media 1 
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2 Listing of activities 2005-2010 
Supervisor or co-supervisor of doctoral thesis 
Anu Suomalainen Wartiovaara ,  
Supervisor of Anna Hakonen's PhD thesis, Anu Suomalainen Wartiovaara, 2002  2009 
Supervisor of Petri Luoma's PhD thesis, Anu Suomalainen Wartiovaara, 2002  2007 
Supervisor of Eino Palin's PhD thesis, Anu Suomalainen Wartiovaara, 2003  …, Finland 
Supervisor of Henna Tyynismaa's PhD thesis, Anu Suomalainen Wartiovaara, 2003  2007 
Supervisor of Nuno Raimundo's PhD thesis, Anu Suomalainen Wartiovaara, 2004  2009 
Supervisor of Emil Ylikallio's PhD thesis, Anu Suomalainen Wartiovaara, 2005  2010, Finland 
Supervisor of Pirjo Isohanni's PhD thesis, Anu Suomalainen Wartiovaara, 2005  2010, Finland 
Supervisor of Alexandra Götz's PhD thesis, Anu Suomalainen Wartiovaara, 2006  …, Finland 
Supervisor of Kati Ahlqvist's PhD, Anu Suomalainen Wartiovaara, 2008  …, Finland 
Supervisor of Jana Buzkova's PhD thesis, Anu Suomalainen Wartiovaara, 2009  …, Finland 
Supervisor of Sofia Ahola-Erkkilä's PhD thesis, Anu Suomalainen Wartiovaara, 2009  …, Finland 
Supervisor of Ilse Paetau's PhD thesis, Anu Suomalainen Wartiovaara, 2010  …, Finland 
Supervisor of Jenni Elo's PhD thesis, Anu Suomalainen Wartiovaara, 2010  …, Finland 
Supervisor of Joni Nikkanen's PhD thesis, Anu Suomalainen Wartiovaara, 2010  …, Finland 
Perttu Lindsberg ,  
Supervision of Krista Nuotio's PhD thesis, Perttu Lindsberg, 2007, Finland 
Supervision of Daniel Strbian's PhD thesis, Perttu Lindsberg, 2008, Finland 
Timo Pyry Juhani Otonkoski ,  
Supervisor of Gao Ru's PhD thesis, Timo Pyry Juhani Otonkoski, 2002  2007, Finland 
Supervisor of HBGS Ph.D student, Timo Pyry Juhani Otonkoski, 2006  2010, Finland 
Supervisor of HBGS Ph.D. student, Timo Pyry Juhani Otonkoski, 2008  …, Finland 
Supervisor of HBGS Ph.D. student, Timo Pyry Juhani Otonkoski, 2010  …, Finland 
Brendan Battersby ,  
Supervisor of Miia Taipale's PhD thesis, Brendan Battersby, 2008  2009 
Supervisor of Heidi Junnila's PhD thesis, Brendan Battersby, 2009  …, Finland 
Supervisor of Riikka Jokinen's PhD thesis, Brendan Battersby, 2009  …, Finland 
Pentti Tienari ,  
Supervisor of Johanna Eerola-Rautio's PhD thesis, Pentti Tienari, 2005  2008, Finland 
Supervisor of Alessandro Bonetti's PhD thesis, Pentti Tienari, 2007  2009, Finland 
Iiris Hovatta ,  
Supervisor of Jonas Donner's PhD thesis, Iiris Hovatta, 2007  …, Finland 
Supervisor of Helena Kilpinen's PhD thesis, Iiris Hovatta, 2008  15.12.2010, Finland 
Supervisor of Tessa Sipilä's PhD thesis, Iiris Hovatta, 2008  …, Finland 
Supervisor of Mari Rossi's PhD thesis, Iiris Hovatta, 2010  …, Finland 
Ove Eriksson-Rosenberg ,  
Supervisor of Zydrune Polianskyte's PhD thesis, Ove Eriksson-Rosenberg, 12.12.2009, Finland 
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Daniel Strbian ,  
Thesis Supervision, Daniel Strbian, 2008  …, Finland 
Thesis Supervision, Daniel Strbian, 2009  … 
Christopher John Carroll ,  
Thesis co-supervision of Jana Buzkova, Christopher John Carroll, 2009  … 
Prizes and awards 
Anu Suomalainen Wartiovaara ,  
Centre of Excellence in Science of the Academy of Finland, Anu Suomalainen Wartiovaara, 2002  2007, Finland 
EMBO Young Investigator, Anu Suomalainen Wartiovaara, 2002  2005 
Sigrid Jusélius Foundation major research grant, Anu Suomalainen Wartiovaara, 2005  2010, Finland 
Membership in Finnish Academy of Science and Letters, Anu Suomalainen Wartiovaara, 2007, Finland 
Sigrid Jusélius Professor of clinical molecular medicine, Anu Suomalainen Wartiovaara, 2007  2011, Finland 
Centre of Excellence in Science of the Academy of Finland, Anu Suomalainen Wartiovaara, 2008  2013, Finland 
Jane and Aatos Erkko Foundation, major grant, Anu Suomalainen Wartiovaara, 2008  2012, Finland 
Perttu Lindsberg ,  
SalusAnsvar Prize in Medicine 2010, Perttu Lindsberg, 2010 
SalusAnswar Prize for Medicine 2010, Perttu Lindsberg, 03.12.2010, Sweden 
Timo Pyry Juhani Otonkoski ,  
Ray and Robert L. Kroc Lecture Award, Timo Pyry Juhani Otonkoski, 11.06.2009, Sweden 
Iiris Hovatta ,  
Suomen L'Oreal-UNESCO Women in Science palkinto, Iiris Hovatta, 2006 
Suomen lääketieteellisen genetiikan yhdistyksen genetiikan palkinto, Iiris Hovatta, 2006, Finland 
Toinen palkinto Human genome meeting posterikilpailussa, Iiris Hovatta, 2006 
Duodecimin kirjoituspalkinto, Iiris Hovatta, 2007, Finland 
Pro gradu -tutkielman hyvä ohjaaja -palkinto, Iiris Hovatta, 2007, Finland 
Posteripalkinto ESF:n Functional Genomics and Disease -kokouksessa, Iiris Hovatta, 2008 
Rosalind Franklin Young Investigator Award, Iiris Hovatta, 2010 
Ove Eriksson-Rosenberg ,  
Oskar Öflunds Stiftelses Stora Pris, Ove Eriksson-Rosenberg, 19.05.2009 
Daniel Strbian ,  
Young Scientist Prize 2006, Daniel Strbian, 2006 
Best thesis of the year 2008, Daniel Strbian, 2009 
Henna Tyynismaa ,  
Best PhD thesis, Faculty of Medicine, University of Helsinki, 2007, Henna Tyynismaa, 2007 
The University of Helsinki Biomedical Thesis Award, Licentia, 2007, Henna Tyynismaa, 2007 
Riikka Jokinen ,  
Best Abstract Award (third prize), Riikka Jokinen, 18.06.2010 
Editor of research journal 
Perttu Lindsberg ,  
Assistant editor of Stroke, Perttu Lindsberg, 2000  2005, United States 
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Timo Pyry Juhani Otonkoski ,  
Diabetologia, Associate Editor, Timo Pyry Juhani Otonkoski, 2008  2010, Germany 
Pentti Tienari ,  
Annals of Neurology, Pentti Tienari, 01.01.2005  31.12.2005, United States 
BRAIN, Pentti Tienari, 01.01.2005  31.12.2005, United Kingdom 
European Journal of Human Genetics, Pentti Tienari, 01.01.2005  31.12.2005, Netherlands 
Member of editorial board of Journal of Medical Genetics, Pentti Tienari, 01.01.2005  31.12.2005, United States 
STROKE, Pentti Tienari, 01.01.2005  31.12.2005, United States 
Daniel Strbian ,  
Current Vascular Pharmacology, Daniel Strbian, 2010  … 
Peer review of manuscripts 
Anu Suomalainen Wartiovaara ,  
Reviewer of articles for international journals, Anu Suomalainen Wartiovaara, 01.01.2002  2011 
Timo Pyry Juhani Otonkoski ,  
DIABETES AND METABOLISM REVIEWS, Timo Pyry Juhani Otonkoski, 01.01.1999  …, United States 
DUODECIM, Timo Pyry Juhani Otonkoski, 01.01.1999  …, Finland 
Diabetes, Timo Pyry Juhani Otonkoski, 01.01.1999  …, United States 
MOLECULAR AND CELLULAR ENDOCRINOLOGY, Timo Pyry Juhani Otonkoski, 01.01.1999  … 
Diabetologia, Timo Pyry Juhani Otonkoski, 01.01.2000  …, Germany 
Endocrinology, Timo Pyry Juhani Otonkoski, 20.01.2001  …, United States 
FEBS Letters, Timo Pyry Juhani Otonkoski, 01.01.2002  …, Germany 
Molecular and Celluar Endocrinology, Timo Pyry Juhani Otonkoski, 01.01.2002  …, Finland 
Journal of Clinical Endocrinology and Metabolism, Timo Pyry Juhani Otonkoski, 01.01.2004  …, United States 
European Journal of Endocrinology, Timo Pyry Juhani Otonkoski, 23.03.2006  …, Germany 
Hormone Research, Timo Pyry Juhani Otonkoski, 23.03.2006  31.12.2011, Germany 
Nature Clinical Practice, Timo Pyry Juhani Otonkoski, 23.03.2006  31.12.2011, United States 
The Lancet, Timo Pyry Juhani Otonkoski, 23.03.2006  31.12.2011, United Kingdom 
Iiris Hovatta ,  
Peer reviewer of 23 scientific journals, Iiris Hovatta, 2004  … 
Karolina Lundin (Stenroos) ,  
Peer review of manuscripts, Karolina Lundin (Stenroos), 22.05.2009  18.06.2009 
Krista Nuotio ,  
Stroke Reviewer, Krista Nuotio, 2003  … 
Daniel Strbian ,  
Brain Research, Daniel Strbian, 2007  … 
European Journal of Neurology, Daniel Strbian, 2007  … 
Neuroscience Letters, Daniel Strbian, 2007  … 
Pharmacology, Biochemistry and Behavior, Daniel Strbian, 2007  … 
Journal of Neuroscience Methods, Daniel Strbian, 2008  … 
Journal of Cerebral Blood Flow and Metabolism, Daniel Strbian, 2008  … 
Neuroscience, Daniel Strbian, 2008  … 
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Computerized Medical Imaging and Graphics, Daniel Strbian, 2009  … 
Stroke, Daniel Strbian, 2009  … 
Case Reports in Neurology, Daniel Strbian, 2010  … 
Experimental &amp; Translational Stroke Medicine, Daniel Strbian, 2010  … 
Henna Tyynismaa ,  
BBA-Molecular Basis of Disease, Henna Tyynismaa, 2009 
Transgenic Research, Henna Tyynismaa, 2009 
American Journal of Human Genetics, Henna Tyynismaa, 2010 
Gene, Henna Tyynismaa, 2010 
Journal of Aging Research, Henna Tyynismaa, 2010 
Journal of Neurology, Henna Tyynismaa, 2010 
Jani Saksi ,  
Stroke, Jani Saksi, 2005  … 
Editor of communication journal 
Timo Pyry Juhani Otonkoski ,  
Member of editorial board of Hyvä Terveys, Timo Pyry Juhani Otonkoski, 2008  2010, Finland 
Assessment of candidates for academic posts 
Anu Suomalainen Wartiovaara ,  
Reviewer of applications for tenure professorship, Anu Suomalainen Wartiovaara, 2005, United States 
Reviewer of applications for tenure professorship, Anu Suomalainen Wartiovaara, 2007, United Kingdom 
Membership or other role in review committee 
Pentti Tienari ,  
MRC grant reviewer, Pentti Tienari, 01.01.2008  31.12.2008 
Daniel Strbian ,  
Medical Research Council (MRC), Daniel Strbian, 2008  …, United Kingdom 
Membership or other role in research network 
Pentti Tienari ,  
ECTRIMS council, Pentti Tienari, 01.01.2008  31.12.2011 
Finnish brain research society, board of directors, Pentti Tienari, 01.01.2008  31.12.2010 
Neuroscience Center, Univ Helsinki, Pentti Tienari, 01.01.2010  31.12.2010 
Iiris Hovatta ,  
Management committee member of SYSGENET COST, Iiris Hovatta, 2009  2012 
Membership or other role in national/international committee, council, board 
Anu Suomalainen Wartiovaara ,  
Evaluation board for Matti Äyräpää prize, Anu Suomalainen Wartiovaara, 2006  2008, Finland 
Board of Biomedicum Research Programs, Anu Suomalainen Wartiovaara, 2007  2008, Finland 
Board of Helsinki University Animal Research Centre, Anu Suomalainen Wartiovaara, 2007  2010, Finland 
Board of United Mitochondrial Disease Foundation, Anu Suomalainen Wartiovaara, 2007  2009, United States 
Duodecim Foundation, grant committee, Anu Suomalainen Wartiovaara, 2007  2009, Finland 
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Editorial board of Mitochondrion, Anu Suomalainen Wartiovaara, 2007  2011, Netherlands 
Grant committee, Anu Suomalainen Wartiovaara, 2007  2009, Finland 
Board of Neuroscience Centre, Anu Suomalainen Wartiovaara, 2008  2010, Finland 
Review board for MRC Unit of Mitochondrial Medicine, Anu Suomalainen Wartiovaara, 16.11.2009  18.11.2009, United Kingdom 
Board of Research Programs Unit, Anu Suomalainen Wartiovaara, 2010  …, Finland 
Bursar's financial working group, Anu Suomalainen Wartiovaara, 2010  …, Finland 
Finnish Cultural Foundation, Anu Suomalainen Wartiovaara, 2010  2011, Finland 
Reviewer of EMBO fellowshiips, Anu Suomalainen Wartiovaara, 31.08.2010, Germany 
Perttu Lindsberg ,  
Executive board member, Perttu Lindsberg, 2002  2006, Finland 
Member in Committee of Experimental Animal Use, Perttu Lindsberg, 2002  2006, Finland 
member of organizing committee of Teach Neurology, Perttu Lindsberg, 2002  …, Hungary 
Member of the committee Current Therapy Guidelines in Stroke, Perttu Lindsberg, 2003  2006, Finland 
Member of Research council, Perttu Lindsberg, 2004  2007, Finland 
Editorian Board member of Stroke, Perttu Lindsberg, 2005  2006, United States 
Head of committee Current Therapy Guidelines in Stroke, Perttu Lindsberg, 2009  …, Finland 
Timo Pyry Juhani Otonkoski ,  
Council of the European Association for the Study of Diabetes, Timo Pyry Juhani Otonkoski, 23.03.2006  …, Germany 
Diabetestutkimussäätiö, tieteellinen valiokunta, Timo Pyry Juhani Otonkoski, 01.01.2006  31.12.2006, Finland 
IDIBELL Scientific Advisory Board, Timo Pyry Juhani Otonkoski, 2007  … 
Institut de Investigacio Biomedica de Bellvitge (IDIBELL), Scientific Advisory Board, Timo Pyry Juhani Otonkoski, 01.01.2007  …, 
Spain 
European Association for the Study of Diabetes, Scientific Program Committee, Timo Pyry Juhani Otonkoski, 01.01.2008  31.12.2008, 
Germany 
Hyvä Terveys, Member of Editorial Board, Timo Pyry Juhani Otonkoski, 2008  2010, Finland 
European Commission, Proposal Evaluation FP7, Timo Pyry Juhani Otonkoski, 10.02.2009  13.02.2009, Belgium 
Translational Medicine Master's Program Steering Committee, Timo Pyry Juhani Otonkoski, 2009  …, Finland 
European Foundation for the Study of Diabetes (EFSD), Timo Pyry Juhani Otonkoski, 08.07.2010 
Pentti Tienari ,  
DEMANDE DE FINANCEMENT DE RECHERCHE SUR LA SCLEROSE EN PLAQUES / ARSEP appel d Offres 2005 Apurahan 
ulkopuolinen ulkomainen arvioitsija, Pentti Tienari, 01.01.2005  31.12.2005, France 
Nordic multiple sclerosis consortium POHJOISMAAT, Pentti Tienari, 01.01.2005  31.12.2005 
Suomen Akatemia, arviointi- paneeli, Pentti Tienari, 17.02.2005, Finland 
Thesis committee, Medical Faculty, Univ Helsinki, Pentti Tienari, 01.01.2007  31.12.2008 
Thesis committee, Medical Faculty, Univ Helsinki, Pentti Tienari, 01.01.2009  31.12.2010 
Iiris Hovatta ,  
Apurahapaneelin asiantuntijasihteeri, Iiris Hovatta, 2005, Finland 
Biomedicum Helsinki Seminar Series organizer, Iiris Hovatta, 2006  2008, Finland 
Tutkijan ura -paneelin jäsen, Iiris Hovatta, 2008, Finland 
Jäsen, Advisory board, Rosalind Franklin Society, Iiris Hovatta, 2009  …, United States 
Johtokunnan jäsen, Helsingin yliopiston koe-eläinkeskus, Iiris Hovatta, 2010  2013 
Jäsen tiedekuntaneuvostossa, Helsingin yliopisto, Iiris Hovatta, 2010  2013, Finland 
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Varajäsen, Helsingin yliopisto Neurotieteen tutkimuskeskuksen johtokunta, Iiris Hovatta, 2010  2013 
Varajäsen, Helsingin yliopisto yliopistokollegio, Iiris Hovatta, 2010  2013 
Varajäsen, MBI-bioinformatiikan maisteriohjelman ohjausryhmä, Iiris Hovatta, 2010  2013 
Daniel Strbian ,  
Stroke Council, Daniel Strbian, 2009  …, United States 
Kati Ahlqvist ,  
Lääketieteellisen tiedekunnan tutkimusohjelmayksikön johtoryhmä, Kati Ahlqvist, 15.03.2010  31.12.2012 
Membership or other role in public Finnish or international organization 
Pentti Tienari ,  
Helsinki and Uusimaa MS society, Pentti Tienari, 01.01.2007  31.12.2010 
Daniel Strbian ,  
Suomen Neurologian Yhdistys, Daniel Strbian, 2010  …, Finland 
Participation in interview for written media 
Anu Suomalainen Wartiovaara ,  
Interview in Hyvä Terveys (Good Health) journal, Anu Suomalainen Wartiovaara, 30.06.2009 
Pentti Tienari ,  
Lehdistöaamiainen (Järjestäjä Sanofi-Aventis OY), Pentti Tienari, 24.08.2005, Finland 
Lääketieteen toimittajat vierailevat Biomedicumissa, Pentti Tienari, 08.09.2005, Finland 
MeSa potilaskerhon kokous, Pentti Tienari, 23.11.2005, Finland 
Pohjankyrö lehti (haastattelu lehden uutista varten), Pentti Tienari, 09.2005, Finland 
Iiris Hovatta ,  
Ahdistus aisoihin, Iiris Hovatta, 2006, Finland 
Biotieteen nuoret lupaukset, Iiris Hovatta, 12.2006, Finland 
Ehdokasgeenejä ahdistuneisuudelle, Iiris Hovatta, 2007, Finland 
Mistä ahdistuneisuushäiriöt johtuvat?, Iiris Hovatta, 2007, Finland 
Mistä ahdistuneisuus kumpuaa?, Iiris Hovatta, 10.2008, Finland 
Tuttu tuntematon masennus, Iiris Hovatta, 2008, Finland 
Tutustu tutkijaan. Geenitutkija selvittää mikä meitä ahdistaa., Iiris Hovatta, 11.2008, Finland 
Kolme viisasta naista, Iiris Hovatta, 04.01.2009, Finland 
Daniel Strbian ,  
Helsinki University, Daniel Strbian, 2008  … 
Participation in radio programme 
Anu Suomalainen Wartiovaara ,  
YLE-Radio, Anu Suomalainen Wartiovaara, 04.06.2009 
Perttu Lindsberg ,  
Reseptori: Aivoen kehitys ja toiminta, Perttu Lindsberg, 06.11.2008, Finland 
Reseptori: Aivojen äkilliset vammat, Perttu Lindsberg, 13.11.2008, Finland 
Pentti Tienari ,  
Interview for YLE radio-1, Pentti Tienari, 10.12.2005 
Interview in YLE radio-1, Pentti Tienari, 11.11.2005 
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YLE radio-1 Reseptori (Leena Mattila), Pentti Tienari, 11.2005, Finland 
YLE radio-1 Tiedeuutiset (Maija Typpi), Pentti Tienari, 10.2005, Finland 
Iiris Hovatta ,  
Periytyykö paniikkihäiriö, Iiris Hovatta, 2007, Finland 
Alttiusgeenejä löytyy myös skitsofrenian ja autismin takaa, Iiris Hovatta, 04.11.2009, Finland 
Johtuuko ahdistuneisuus geeneistä, Iiris Hovatta, 14.10.2009, Finland 
Participation in TV programme 
Anu Suomalainen Wartiovaara ,  
Läpimurto MTV3 program; a documentary of Wartiovaara's research, Anu Suomalainen Wartiovaara, 01.11.2005, Finland 
Interview in YLE-news, Anu Suomalainen Wartiovaara, 03.06.2009 
Pentti Tienari ,  
TV interview 24.8.2005 (YLE-1 evening news), Pentti Tienari, 08.12.2005 
24.11.2010 Interview in Finnish television YLE1 A-Studio, Pentti Tienari, 11.12.2010 
Iiris Hovatta ,  
Tutkiva juttu, Iiris Hovatta, 04.2008, Finland 
Participation in interview for web based media 
Krista Nuotio ,  
Husari haastattelu, Krista Nuotio, 28.01.2008, Finland 
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Web of Science(WoS)-based bibliometrics of the RC’s publications data 1.1.2005-31.12.2010  
by CWTS, Leiden University, the Netherlands 
Research Group: Wartiovaara A 
Basic statistics 
Number of publications (P) 214 
Number of citations (TCS) 2,210 
Number of citations per publication (MCS)  10.70 
Percentage of uncited publications 21% 
Field-normalized number of citations per publication (MNCS)   1.46 
Field-normalized average journal impact (MNJS)   1.57 
Field-normalized proportion highly cited publications (top 10%)   1.51 
Internal coverage    .94 
 
Trend analyses 
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Performance (MNCS) by collaboration type 
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